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ABSTRACT 
Birth weight is the single most important marker of perinatal 
and neonatal outcome. India contributes to 25% of the world’s 
total neonatal deaths. The role of micronutrients in causing low 
birth weight in term babies has been unclear. This study was done 
to study the cord blood zinc level in term small for gestational age 
babies and to find whether low zinc level is an cause for low birth 
weight in term babies. We studied the cord blood zinc level of 50 
term small for gestational age babies and 50 term appropriate for 
gestational age babies. Term small for gestational age babies were 
selected after excluding most of the causes of low birth weight. 
Maternal and baby’s parameters were recorded. There was no 
significant difference in the cord blood zinc level between both the 
study groups. There was no significant difference in the maternal 
age, parity, mode of delivery and sex of the baby between both the 
study groups. Also there was no significance between zinc level 
and maternal age, parity, mode of delivery and the sex of the baby 
in both the study groups. Thus zinc deficiency alone cannot be an 
etiology for low birth weight in term babies.           
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INTRODUCTION 
 
Birth weight is the single most important marker of perinatal and 
neonatal outcome. A new born weighing less than 2500 grams at birth 
irrespective of the gestational age is termed as a low birth weight neonate. 
The incidence of low birth weight in India is around 28%, accounting for 6-
8 million babies, which is around 40% of the global burden1. Low birth 
weight babies can be term- small for gestational age or preterm babies. 
 
In the western world, the major cause of low birth weight is 
prematurity. In contrast to the western world, in India the main cause of low 
birth weight is intrauterine growth restriction and not prematurity2. Thus 
around two third of the low birth weight neonates in India are term-small for 
gestational age babies and one third are preterm babies. Most of the low 
birth weight neonates in India weigh between 2000-2499 grams. 
 
These babies are at an increased risk of morbidity and mortality. They 
are prone to immediate complications like asphyxia, sepsis, metabolic 
problems, hypothermia and they may also have feeding problems3. They are 
also prone to long term complications like growth failure, infection, 
developmental problems and malnutrition3. They are also at a high risk of 
developing diabetes mellitus, hypertension, coronary artery disease and 
stroke as suggested by the Barker hypothesis4. Thus improving the birth 
11 
 
weight of the neonate becomes a most important measure to prevent 
neonatal mortality. 
 
Low birth weight neonates may have a low nutritional reserve, 
especially micronutrients, out of which zinc is an important one. Zinc is a 
trace element that is found in abundance next to iron. Zinc is a vital 
component of cell architecture and function. It is required for the production 
of many enzymes involved in nucleic acid metabolism and protein synthesis, 
which are the essential processes of growth. It has an important role in gene 
transcription. Zinc finger containing transcription factors play an important 
role in protein-DNA or protein –RNA interactions5. 
 
Zinc deficiency in mothers may lead to adverse pregnancy outcomes 
like spontaneous abortion, congenital malformations, preterm birth and low 
birth weight5. It can lead to poor weight gain, growth retardation, reduced 
immunocompetence and infection. However, two recent meta-analyses on 
randomised controlled trials of maternal zinc supplementation on pregnancy 
and infant outcomes revealed that zinc supplementation did not  
significantly improve the birth weight, head circumference  or birth length6,. 
Thus this area remains a subject of debate. 
 
This study aims at finding an association between cord blood zinc 
level and birth weight in term babies-both small for gestational age and 
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appropriate for gestational age. Several studies have been done on this 
subject, some of the studies have reported a positive correlation between 
zinc and birth weight, while some of the studies deny such correlation.  
After controlling many maternal and fetal factors that lead to low birth 
weight, the association between zinc level and birth weight is assessed.  
Thus this may assess the role of zinc as an etiology for low birth weight in 
term small for gestational age neonates. 
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SMALL FOR GESTATIONAL AGE BABIES 
 
A neonate whose birth weight falls less than the 10th percentile for 
that gestational age is termed as small for gestational age3. 
Intrauterine growth retardation is termed as a condition in which a 
fetus is unable to achieve its genetically determined growth potential size 
and represents a deviation and a reduction in the expected growth pattern8. 
There is a diminished growth velocity of the fetus in atleast two intrauterine 
growth assessments. 
 
FETAL GROWTH 
Life begins when a sperm fertilises the ovum resulting in a 
microscopic monocellular zygote. It has X chromosome from the mother or 
the father and Y chromosome from the father. It has a enormous growth 
potential. It grows from a weight of 0.005 mg at conception to an average 
weight of 3kg at term. In the first trimester, growth occurs by differentiation 
of vital organs. Organogenesis is completed by 10-20 weeks. After 12 
weeks, there is a rapid increase in weight. 
 
During the second trimester, increase in length is proportionately 
greater than the increase in weight. In the third trimester there is a rapid 
increase in the weight of the fetus. The birth weight of a baby is 5% of the 
adult weight but the brain weighs 60% of the adult brain. Thus brain growth 
14 
 
is faster in the fetal period. In short, growth occurs by increase in cell 
number during the earlier weeks, and by increase in cell size during the later 
trimesters. Thus an insult in the early trimester affects the cell number 
leading to diminished growth potential. When the insult is late, baby will 
have normal number of small sized cells. 
 
CLASSIFICATION OF SMALL FOR GESTATIONAL AGE BABIES
8 
1. Asymmetric IUGR 
2. Symmetric IUGR 
It is differentiated by the Ponderal index as below 
Ponderal index=  
  	
 
  	
 × 100   
            Asymmetric IUGR-Ponderal index < 2 
            Symmetric IUGR-Ponderal index >2 
 
ASYMMETRIC IUGR 
The fetus is affected during the later trimesters, thus the cell number 
is not affected. Only the cell size is affected. The head circumference and 
the brain growth are not affected which is called the brain sparing effect on 
the fetus. Thus their growth potential is not affected. They usually result 
from placental insufficiency or maternal malnutrition. 
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SYMMETRIC IUGR 
The fetus is affected in the early trimester, thus the cell number is 
affected. The growth potential of the fetus is reduced. The baby is 
proportionately small. Weight, length and the head circumference are all 
affected. They are usually due to congenital anomalies or chromosomal 
abnormalities. 
 
CAUSES OF SMALL FOR GESTATIONAL AGE BABIES
8 
1. Fetal factors 
2. Maternal factors 
3. Placental factors 
 
FETAL FACTORS 
1. Constitutional 
2. Chromosomal syndromes. 
3. Malformations 
4. Infection 
5. Multiple pregnancy. 
 
MATERNAL FACTORS 
1. Genetic 
2. Constitutional 
3. Pregnancy induced hypertension.  
16 
 
4. Ill health-heart disease, hemoglobinopathies, chronic anemia, 
asthma, vasculitis, chronic hypertension, diabetes, renal disease, 
pregnancy induced hypertension 
5. Malnutrition 
6. Anemia 
7. Low socioeconomic status 
8. Low pre pregnancy weight gain. 
9. Drugs 
10. Uterine malformatio 
11. Smoking 
12. Alcohol 
13. Infections-TORCH 
 
PLACENTAL FACTORS 
1. Poor placentation 
2. Pre eclampsia 
3. Placental praevia 
4. Abruptio placenta 
5. Vascular abnormalities - single umbilical artery, velamentous 
insertion of the cord, twin to twin transfusion 
6. Malformations - chorioangioma, infarction, circumvallate 
placenta  
17 
 
COMPLICATIONS
3 
1. Fetal hypoxia and intrapartum death due to placental dysfunction 
2. Perinatal depression 
3. Meconium aspiration 
4. Pulmonary hemorrhage 
5. Persistent pulmonary hypertension 
6. Hypotension 
7. Hypothermia 
8. Hypoglycemia 
9. Hypocalcemia 
10. Polycythemia 
11. Hyperbilirubinemia 
12. Neutropenia 
13. Thrombocytopenia 
14. Acute tubular necrosis/renal insufficiency 
15. Vulnerability to infections 
16. Poor growth potential 
17. Long term complications-diabetes mellitus, hypertension and 
coronary artery disease. 
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MANAGEMENT       
DURING PREGNANCY
3 
1. The cause should be identified and treated. 
 
2. Once the diagnosis is made, the fetal well being should be 
monitored by biophysical profile, fetal movement counts, serial 
ultrasound examination. Doppler evaluation of the placental flow 
can be used to detect uteroplacental insufficiency. 
3. If early delivery is necessary, fetal lung maturity should be 
considered. antenatal steroids may be given when the delivery is 
planned before 34 weeks of gestation. 
4. Decision of delivery 
 
a. Reversal of end diastolic umbilical artery flow – deliver 
 
b. Absent end diastolic umbilical artery flow   
i. >/=34 weeks-deliver  
ii. <34 weeks-daily  non stress test  
deliver if NST nonreactive or BPP score>6. 
c. Oligohydramnios 
i. >/=34 weeks-deliver if cervix is favourable. 
ii. <34 weeks-daily NST- 
deliver if NST non reactive or BPP 
score>/=6 or absent end diastolic umbilical 
artery blood flow. 
d. Normal Doppler/BPP –continue antenatal surveillance. 
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DELIVERY 
Steroids can be used if amniotic fluid analysis suggests pulmonary 
immaturity. When the placental blood flow is poor, the fetus may not 
tolerate labour and needs caesarean section. They are at a risk of perinatal 
hypoxia, meconium aspiration, hypothermia. Thus the resuscitation team 
must be ready to face them. Due to the above complications, the delivery 
should be planned in a higher centre with a good NICU. 
 
POST PARTUM 
Cause should be identified baby should be examined for congenital 
anomalies/stigmata of intrauterine infection3. Ponderal index should be 
determined baby should be nursed in a warm environment. Early breast 
feeding should be initiated to prevent hypoglycemia. The complications 
enlisted above have to be anticipated and treated effectively. 
 
PROGNOSIS AND LONG TERM IMPLICATIONS  
Small for gestational age babies have a lower risk of mortality when 
compared to preterm appropriate for gestational age babies. But they have a 
higher risk of mortality and morbidity when compared to term appropriate 
for gestational age babies3. They are at a higher risk for poor postnatal 
growth, neurologic impairment, delayed cognitive impairment and poor 
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academic achievement. According to Barker’s hypothesis, they are prone to 
develop insulin resistance, diabetes and coronary artery disease4. 
 
Thus improving the birth weight of the baby decreases the morbidity 
in the later years thus improving the quality of life. 
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TRACE ELEMENTS 
Trace element is an element that constitutes less than 0.01% of the 
total body weight9. They play a vital role in metabolic processes as they are 
components of many enzyme systems. They are a part of metalloenzymes 
and cofactors that are needed for enzymes9. Trace element deficiencies are 
being reported in humans and they have deleterious effects on the health, 
growth and development. Thus it becomes a field of interest for the 
Paediatricians.  
Thirteen trace elements are considered to be most important for higher 
animals. They are in order of importance as follows 9 
1.Iron 
2. Zinc 
3. Copper 
4. Fluoride 
5. Iodine 
6. Selenium 
7. Manganese 
8. Chromium 
9. Cobalt 
10. Molybdenum 
11. Nickel 
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12. Silicon  
13. Vanadium 
 
Thus zinc stands second in order of importance next to iron. It also 
stands second next to iron in order of abundance in the human body. Thus 
zinc has progressed from a micronutrient of doubtful significance to a one 
with exceptional biologic importance .Thus it plays an important role in 
early development, both prenatal and postnatal. Thus its basic biochemistry, 
physiology and its metabolism in the maternal-placental unit and in the 
neonate has to be discussed to analyse its effects on the neonate.           
 
ZINC 
BIOCHEMISTRY OF ZINC 
Zinc   has an atomic weight of 65.39 and is adjacent to several first 
order elements of biologic importance. But its biochemical properties vary 
from other elements of similar atomic weight. Zinc is distributed evenly 
throughout the body. It is a component of metalloproteins and nucleic acids5. 
Two important properties of zinc that aid in biologic activity are: 
 
1. Its capacity to form strong, yet readily exchangeable ligand binding. 
2. Flexibility of the coordination geometry. 
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These two properties aid in the unique ability of the metal to interact 
with a wide range of organic ligands and thus its role in biologic systems5. 
The main aminoacids that supply ligands to zinc are histidine, glutamic acid, 
aspartic acid and cysteine5. Zinc affects the tertiary and the quarternary 
structure of the proteins which is important for the reactivity of the metal. 
Zinc participates in redox reactions in certain circumstances. In contrast to 
iron and copper, zinc per se has no oxidant properties and it remains in the 
divalent state. Thus this facilitates safe transport of zinc aiding in 
incorporation in to biologic systems5. The biological role of zinc can be 
recognized in the structure and function of proteins which includes enzymes, 
transcription factors, hormonal receptor sites and cell membranes. Zinc has 
several roles in DNA and RNA metabolism, it has a role in signal 
transduction, gene expression and apoptosis5. 
 
Zinc is a part of the structure of the enzymes. Yet its importance lies 
in being a component of the catalytic site of the several metalloenzymes. 
Many of the enzymes involved in cellular proliferation, differentiation, 
nucleic acid metabolism and growth are zinc dependent enzymes. Several 
zinc finger containing proteins have been identified. Zinc finger motif is a 
tetrahedral structure containing recurring pattern of aminoacids with 
conserved residues of cysteine and histidine to which zinc binds5.                       
Almost >3% of the human genes contain zinc finger domains. Zinc plays an 
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important role in transcription, thus it mediates and modulates gene 
expression. Hence it is essential for the early development. 
 
Zinc is an important regulator of apoptosis. It protects the cell from 
apoptosis as it downregulates the main pathways involved in apoptosis. It 
has also got a direct influence on the caspases which are the key enzymes in 
apoptosis. Thus a decrease in the intracellular zinc can trigger the apoptotic 
pathways leading to activation of caspases5.  
 
Zinc is involved in signal transduction5. Zinc is sequestered in the 
presynaptic vesicles of the neurons containing zinc. Zinc is released from 
these neurons into the cleft from where it is recycled back to the neurons. 
This vesicular zinc that is released acts as a neurotransmitter and a 
neuromodulator. The main role of this vesicular zinc lies in the tonic 
modulation of the excitability of the brain. 
 
Vesicular zinc rich regions include the hippocampus which is most 
sensitive to zinc deprivation resulting in brain dysfunction, learning 
disability and high susceptibility to seizures. The above facts reinforce the 
importance of zinc for normal neuronal function. Thus normal neuronal 
function needs a normal zinc homeostasis5. Metallothionein is a small 
intracellular protein with a metal binding capacity. It has four isoforms. It is 
usually found in all the tissues. It is found in pl
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intestine and the kidney. Isoforms 1 and 2 are abundant. Isoform 3 is found 
in brain. Zinc is an inducer of metallothionein. Zinc’s role in transcription is 
related to metal response element-binding transcription factor-1 which is a 
cellular zinc sensor5. Other inducers of metallothionein are cytokines 
interleukin-6, tumour necrosis factor alpha and stress hormones –
corticosteroids and catecholamines. Metallothionein is an antioxidant. 
Factors that induce maternal hepatic metallothionein during early trimesters 
may direct the zinc from the conceptus to the maternal liver. Thus the fetus 
may become zinc deficient. This is the mechanism that occurs in fetal 
alcohol syndrome5. 
 
PHYSIOLOGY OF ZINC 
Zinc is absorbed in the small intestine by active transport. Zinc 
homeostasis is maintained by both uptake and endogenous secretion. This is 
done by two families of zinc transporters, the ZIP family (1-5) and ZnT 
family (1-14)5,9. ZIP family regulates uptake of zinc into the cells. ZnT 
family regulates zinc efflux and intracellular compartmentalization. These 
are affected by zinc intake. It is transported in serum as a bound form with 
albumin and alpha 2 macroglobulin. Further metabolism occurs in the liver. 
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MATERNAL METABOLISM 
There is an increase in the metallothionein in the liver which may 
increase the zinc store. But when the plasma zinc is diverted to the liver in 
fetal alcohol syndrome, zinc deficiency may occur. As the pregnancy 
progresses, there is a decrease in the maternal zinc level5. When this 
decrease is excessive due to maternal zinc deprivation or abnormal 
metabolism, zinc deficiency may occur. 
 
PLACENTAL AND FETAL METABOLISM 
Transfer of zinc from the mother to the fetus starts with the uptake of 
zinc in to the placental syncytiotrophoblast. This is usually from the 
maternal plasma pool by a carrier mediated process5. It also occurs from 
zinc bound to protein by an endocytic mechanism. Affinity of the placental 
syncytiotrophoblast microvillus membrane vesicles to zinc does not vary 
with the gestational age or the maternal plasma level. 
 
The uptake capacity of zinc is higher in preterm than in term and with 
low maternal zinc level. Changes in fetal zinc for a short time does not cause 
a change in placental zinc transfer. Thus there is no immediate adjusting 
mechanism for fetal zinc deprivation5. Fetal hepatic zinc increases as the 
gestation increases. This decreases late in the third trimester. 
Metallothioneins are essential for the maintenance of pregnancy. 
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MAMMARY GLAND METABOLISM 
Concentration of zinc in the milk is regulated by a set of transporters 
ZnT1, ZnT2 and ZnT45.Vitamin A may have a role in zinc metabolism in 
the mammary gland. There is a decrease in the zinc in the human milk as the 
lactataion progresses. Rarely when there is a deficiency in the zinc 
transporter ZnT45, the clinical syndrome of acrodermatitis enteropathica 
results. 
 
ZINC HOMEOSTASIS 
Small intestine plays an important role in zinc homeostasis. Maximum 
absorption is by a saturable transport mechanism. Fractional absorption of 
zinc declines with raising the zinc intake and viceversa. Apart from the 
facilitated diffusion, passive diffusion also plays a role and this contributes 
when the facilitated diffusion is saturated5. The major routes of excretion of 
endogenous zinc are the pancreas and the small intestine. Thus zinc 
homeostasis depends on the regulation of the excretion of endogenous zinc. 
In term infants, this regulation of endogenous zinc via the small intestine is 
well developed. 
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ZINC DEFICIENCY IN THE CONCEPTUS AND EARLY INFANCY 
EMBRYOGENESIS 
Zinc is critically needed for the development of the oocyte and the 
embryo. There is evidence that in mothers with acrodematitis enteropathica, 
severe zinc deficiency resulted in neural tube defects and other congenital 
malformations .There are studies where  adequate maternal supplementation 
from 8-10 weeks of gestational age resulted in a significant decrease in the 
incidence of the malformations.  
 
FETAL DEVELOPMENT 
The effects of maternal zinc deprivation during fetal development in 
rodent models are intrauterine growth retardation and decreased nestin 
which is a marker of proliferation of the neural stem cell. Human studies 
show controversial reports on the effect of maternal zinc supplementation on 
the gestational age at delivery and birth weight6,7. But there are reports that 
show a decrease in the morbidity of infants with maternal zinc 
supplementation during the second and third trimesters. These reports 
explain the role of zinc on the developing immune system. 
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INFANCY 
Zinc deficiency in infancy has been classified in to 
1. acute or severe  
2. mild forms. 
 
The prototype of the acute severe presentation is acrodermatitis 
enteropathica5. It is an autosomal recessive disorder. It usually presents 
between 2 and 6 months of age, though the presentation may also be delayed 
in zinc fortified formula fed infants. Breast milk was found to have some 
benefit as breast fed infants had a later onset of the disease compared to 
unfortified formula fed infants. The most pathognomonic clinical feature is 
the skin rash over the body orifices and the extremities. The triad of clinical 
features include diarrhoea, hair loss and the typical skin rash5. 
 
When untreated it results in apathy, growth failure and recurrent 
infections, leading to death. Zinc usually affects cells that have a rapid 
turnover that includes the skin, intestinal mucosa and the immune system. 
Thus immune system abnormalities and growth failure are observed in 
acrodermatitis enteropathica. Globally, zinc deficiency is a major public 
health problem. Studies indicate that around 20-25% of diarrhoea and 40% 
of pneumonia can be prevented by adequate zinc supplementation5. 
Improvements in linear growth, weight gain, brain function and 
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development have been documented after correction of the zinc deficiency.   
Low birth weight babies are at a higher risk from zinc deficiency and its 
effects. In our country, zinc supplementation from the neonatal period have 
shown improvements in growth, decrease in morbidity due to decrease in 
infection. The brain function and development is also better after zinc 
supplementation.        
 
ZINC AND DIET 
SOURCES 
Zinc is rich in oysters, liver, meat, cheese, legumes and whole grains9. 
 
RECOMMENDED DIETARY ALLOWANCE
9 
INFANTS 
0-6 months-2mg/day 
7-12 months-3 mg /day 
 
CHILDREN 
1-3 years-3 mg/day 
4-8 years-5 mg/day 
 
ADOLESCENT MALES 
9-13 years-8mg/day 
14-18years-11 mg/day 
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ADOLESCENT FEMALES 
9-13 years-8 mg/day 
14-18 years-9 mg/day 
 
Zinc absorption is higher from human milk than in cow’s milk. This is 
due to its higher bioavailability as zinc is loosely bound to citrate and 
albumin in human milk9. In cows milk zinc is tightly bound to casein 
resulting in low bioavailability. Phytate rich foods limit zinc absorption9. 
High intake of foods rich in phytate and low intake of foods rich in zinc such 
as meat results in zinc deficiency in our country. High level of iron 
supplementation may impair the zinc absorption9. Combined 
supplementation of zinc and iron resulted in a lower zinc status than with 
zinc supplements alone. As both are essential trace elements. The correct 
dosing in which the two elements do not react adversely have to be 
identified to attain the maximum benefits of zinc supplementation.  
 
The concentration of zinc in human milk in the early post natal period 
is around 2-3mg/L. It decreases to around 0.5mg/L at around 6 months9. So 
this may be inadequate for the baby for its growth. Moreover this is the 
period when the complementary foods are introduced and this period is 
critical for the baby as it is prone to multiple nutrient deficiencies. 
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REVIEW OF LITERATURE 
 
A study on umbilical cord blood nutrients in low birth weight babies in 
relation to birth weight and gestational age by K E Elizabeth et al
10
.  
 
In this study, several nutrients in the cord blood of newborns were 
studied. The study groups included term appropriate for gestational age 
babies (249), term Small for gestational age babies (192) and preterm babies 
(59).The nutrients studied included total protein, albumin, cholesterol, 
triglycerides, calcium, magnesium, zinc and iron. All these parameters were 
lowest in preterm followed by term small for gestational age and Term 
appropriate for gestational age babies.  
 
Peripheral blood leucocyte zinc depletion in babies with intrauterine 
growth retardation by N Meadows et al 
11 
 
In this study, peripheral blood leucocyte and plasma zinc level of 
mother and babies were done. The study groups were normal term (63), 
preterms (20), acute IUGR (term SGA) (19) and prolonged IUGR (term 
IUGR) (8). Leucocyte zinc was comparatively low in acute IUGR, but was 
insignificant. Leucocyte zinc level was significantly low in prolonged 
IUGR, was normal in term controls and slightly higher in preterms. Plasma 
zinc level in the fetus was comparatively the same in all the four groups. 
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There was no significant relation between the maternal and fetal plasma zinc 
level. There was a significant correlation between the leucocyte zinc level in 
the mother and the fetus.  
 
Some essential elements in maternal and cord blood in relation to birth 
weight and gestational age by S Srivastava et al 
12 
 
Maternal and cord blood level of three trace elements, zinc, copper 
and iron was studied in 54 mothers and babies. The study groups were low 
birth weight and normal birth weight babies. Zinc level in the cord blood 
was low in low birth weight babies but was not significant. There was no 
significant difference between the gestational age and cord blood zinc level. 
A weak significant correlation existed between the cord blood iron and birth 
weight. Another weak significant relation was between the gestational age 
and the cord blood iron and copper level.  
 
Leucocyte and plasma zinc in maternal and cord blood –relationship to 
gestational age and birth weight by Aminul Islam et al
13 
 
In this study, 63 mothers and babies were included. The study groups 
were term appropriate for gestational age (33) and term small for gestational 
age or preterm (30). Maternal and cord blood zinc level had no relation to 
birth weight. Plasma copper had an inverse relationship to zinc levels. The 
34 
 
cord blood zinc levels were significantly greater when compared to the 
maternal zinc level. 
 
Zinc and birth weight in uncomplicated pregnancies by T T Lao et al
14 
Zinc status was studied in 59 primiparous and 27 multiparous mothers 
who delivered term babies. The parameters studied were plasma zinc level 
of the mother and the fetus, tissue zinc level from the mothers pubic hair and 
the umbilical cord. No correlation was found between the maternal or fetal 
plasma zinc level and the birth weight. There was no correlation between the 
maternal or fetal tissue zinc level and the birth weight as well. Zinc status 
was significantly higher in the plasma of the neonates than in the maternal 
plasma. Tissue zinc concentration was significantly higher in the mother 
than in the neonate. There was no significance between parity and the 
neonates zinc status.  
 
Serum zinc and copper level in the maternal and cord blood of neonates 
by A S K Iqbal et al
15 
Maternal and cord blood zinc level were assessed in 65 mothers and 
their babies. Out of these 33 were term babies and 32 were preterm babies. 
Cord blood zinc level had no significant difference between the term and 
preterm babies, but copper levels were higher in preterm than the term 
babies. There was no significant correlation between the  cord blood zinc 
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level  or maternal blood zinc level and the birth weight. But there was 
significant relation between the birth weight and the cord blood copper 
level. There was no significant relation between the cord blood zinc level or 
maternal zinc level and the gestational age of the baby.  
 
Maternal and cord blood zinc level in healthy pregnant Jordanian 
women by S M Awadallah et al 
16 
 
 Maternal and cord blood levels of zinc, copper and iron were 
estimated in 92 mothers and their babies. Serum zinc level was significantly 
low in the cord blood than in the maternal blood. As the pregnancy 
progressed the serum zinc level decreased while the serum copper level 
increased. Serum iron level was unchanged in all the three trimesters. There 
was a significant positive correlation between the cord blood zinc level and 
the weight of the baby at birth.  
 
Association between calcium, magnesium, phosphorus, copper and zinc 
in cord plasma and erythrocytes – gestational age and growth variables 
of full term new borns by Michelle Speich et al
17 
 
Cord blood levels of several nutrients were studied in term 
appropriate for gestational age babies. Only uncomplicated pregnancies 
were included and all were delivered by labour naturale. All were healthy 
36 
 
mothers and had no chronic diseases. Erythrocyte zinc and plasma zinc were 
the most significant variables responsible for birth weight. A significant 
positive correlation was observed between the gestational age and the 
growth variables.  
 
Profile of trace element concentrations in the feto placental unit in 
relation to fetal growth by Osada H, Watanabe Y et al
18 
 
Serum levels of manganese, magnesium, iron, copper, zinc and 
selenium were determined in 21 mothers along with their babies who had 
intra uterine growth restriction. 30 term appropriate for gestational age 
babies along with their mothers were also included as controls. Copper, 
selenium, magnesium and zinc were elevated in the umbilical arterial blood 
in IUGR babies. There was no significant difference in the level of these 
trace elements between the study groups.  
 
Trace elements and growth factors in the perinatal period by Diaz 
Gomez NM et al 
19 
 
In this study, cord blood level of copper, zinc, insulin like growth 
factor I levels were measured in all the three study groups, term, preterm, 
term low birth weight. It was found that the cord blood zinc level was low in 
preterm and intrauterine growth retardation babies. 
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 Maternal zinc and cord blood zinc, insulin like growth factor-1, 
insulin like growth factor binding protein 3 levels in small for 
gestational age neonates by Akman et al
20 
 In this study, cord blood level of zinc, insulin like growth factor -1, 
insulin like growth factor -1 binding protein -3 were measured. Term small 
for gestational age babies (22) and term appropriate for age babies (34) and 
their mothers were included. There was positive correlation between 
maternal and neonatal zinc level. Zinc was not low in term SGA 
babies.IGF1 and IGFBP3 were significantly low in SGA than the AGA 
babies. Significant correlation was found between IGF1, IGFBP3 and birth 
weight.  
 
A study of serum zinc level in cord blood of neonates and their mothers 
by Jeswani et al 
21 
Cord blood zinc levels were estimated in the cord blood of 60 new 
born babies. The study group consisted of term AGA, term SGA and 
preterm babies. Serum zinc level was significantly low in term SGA and 
preterm than term appropriate for gestational age babies. There was a 
positive correlation between gestational age and cord blood zinc level and a 
negative correlation between the maternal blood zinc level and gestational 
age. There was a positive correlation between cord blood serum zinc level 
and birth weight.  
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Assessment of maternal fetal status of some essential trace elements in 
pregnant women; relationship with birth weight and placental weight 
by Al-Saleh E et al
22 
 
In this study, cord blood level of copper, iron, zinc and selenium were 
assessed in the maternal and cord blood .The study group consisted of term 
–normal birth weight babies. There was no correlation between the maternal 
zinc level and the birth weight of the neonate. There was a negative 
correlation between the umbilical venous copper level and birth weight. 
There was a positive correlation between the cord blood iron or 
molybdenum and placental weight and a negative correlation between the 
cord blood zinc level and placental weight.  
 
Maternal zinc indices and small babies by George et al 
23
  
 
In this study, zinc status was assessed in mothers of term appropriate 
for gestational age and term small for gestational age babies. Maternal zinc 
level had no positive correlation with the birth weight of the babies. Thus 
this study concluded that maternal zinc was not a cause for intrauterine 
growth restriction.  
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Zinc level of maternal and umbilical venous blood in normal, small for 
gestational age and large for gestational age by Doszpod J et al 
24 
In this study, cord blood zinc were measured in 482 deliveries.241 
cases had normal birth weight babies, 241 mothers had babies with 
intrauterine growth retardation. Zinc concentration was significantly high in 
IUGR babies. Zinc level in 91 IUGR babies were lower than their mothers. 
There was no significant difference in the maternal or cord blood of 59 large 
for date newborn and 56 normal newborns. 
 
Zinc levels in human milk and umbilical cord blood by A Frkovic et al
25 
 
Zinc levels in the human milk (n=29) and the umbilical cord blood 
(n=42) were estimated .Among the forty two babies, thirty eight were term 
babies and only four were preterms. They analysed the zinc levels with 
regard to maternal factors .According to this study parity had significance 
when compared with the zinc level in both milk and cord blood. Primiparae 
had a higher zinc content level. Young mothers had a higher zinc 
concentration. There was a weak association between the zinc levels in the 
umbilical cord and the birth weight, head circumference of the neonates. 
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Intrauterine growth restriction and zinc concentrations in term infants 
by Renato Takeshi Yamada et al
26 
This study analysed the plasma zinc and erythrocyte zinc level in 
intrauterine growth restricted babies. The babies were divided in to three 
groups –without intrauterine growth restriction, with mild to moderate 
intrauterine growth restriction, severe intrauterine growth restriction based 
on the Kramer index. Plasma zinc decreased towards the first month of life. 
Erythrocyte zinc level increased towards the first month of life in IUGR 
babies. 
 
A positive association between maternal serum zinc and birth weight by 
Neggers Y et al 
27 
In this study four hundred and seventy six women attending the 
prenatal clinic were recruited and their serum zinc levels were ascertained. 
The birth weight of all their babies were recorded and analysed .According 
to this study, mothers with a lower zinc level had low birth weight compared 
to those with higher zinc level. Mothers whose zinc level fell in the lowest 
quartile had significantly low birth weight babies than those mothers whose 
zinc level were in the upper three quartiles.  
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Serum zinc and copper in maternal and umbilical cord blood relation to 
the course and outcome of pregnancy by Bro S et al 
28 
 
In this study serum zinc and serum copper levels were estimated in 
the mother and the baby. They were analysed in three groups-term normal 
weight babies, term low birth weight babies and preterms .Serum copper 
level in small for date babies and mothers were in the higher range .There 
was no significance between the serum zinc level and birth weight in small 
for date babies. Preterms had lower serum copper level than term babies and 
there was no difference in the serum zinc level when compared with the 
term babies.  Those babies with malformations did not have any difference 
in the serum zinc and copper level when compared with the normal term 
babies. 
 
Relationship of zinc and copper in maternal and cord blood and birth 
weight Atinmo T et al 
29 
 
In this study fifty pregnant women were selected for the study. Out of 
these twenty delivered babies with birth weight ranging from 1500 grams to 
2500 grams, thirty delivered babies with birth weight more than 2500 grams. 
The cord blood and the maternal blood were collected and sent for analysis 
of serum zinc and copper. The plasma zinc was significantly low in both the 
maternal and cord blood of low birth weight babies. Plasma copper was 
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significantly elevated in the maternal and cord blood of the low birth weight 
babies. Serum zinc level in the maternal blood was less than that of in the 
cord blood. Serum copper level was higher in the maternal blood than the 
cord blood.  
 
Maternal hypozincemia and low birth weight babies by  
Prem Prakash Singh et al 
30 
 
In this study blood was collected from ninety two pairs of mothers 
and babies. All the mothers delivered their babies vaginally and all the 
babies were full term babies. Blood was analysed for serum zinc level. In 
this study they found that the mothers who had a zinc level less than 500 
micrograms/litre had a significantly high level of low birth weight babies. 
 
Plasma zinc and copper in pregnant Nigerian women at term and their 
new born babies by Okonofua FE et al 
31 
 
The sample population included 26 normal Nigerian women and their 
neonates. Maternal and cord blood zinc level were determined and the 
parameters were analysed. In this study there was no significant correlation 
between the maternal and cord blood zinc. Maternal copper level had a weak 
correlation with the cord blood copper. Birth weight did not have any 
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significant correlation with the cord blood zinc. Maternal and cord blood 
copper had an inverse relationship with birth weight. 
 
Plasma trace elements in maternal and cord blood in Poland, relation 
with birth weight, gestational age and parity by Wasowicz et al 
32 
 
In this study the concentrations of zinc, selenium and copper were 
estimated in the plasma of sixty four mothers at delivery. The study 
population also included sixty four neonates, twelve infants aged 2-12 
months and fifty eight non pregnant women. There was no significant 
difference between maternal, cord blood zinc and birth weight of the 
neonate. There was a significant correlation between selenium level in the 
mother and the baby and birth weight. Plasma copper level also had 
significance with birth weight. There was no significant correlation between 
maternal parity and trace elements level. 
 
Serum zinc, copper and iron status in maternal and cord blood by 
Chitra Upadhyaya et al 
33 
 
The study population of this group was around eighty pregnant 
women. Among them, forty six of them were not anemic and thirty four of 
them had anemia. Serum zinc level in pregnancy was significantly reduced. 
But zinc in newborns was significantly higher than that of their mothers. 
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This study highlighted the interactions between the micronutrients. Iron 
affects the bioavailability of zinc and copper. Zinc affects the bioavailability 
of iron and copper. 
 
Maternal zinc and intrauterine growth retardation by Simmer K et al
34 
 
Zinc level was measured in the plasma, erythrocyte, 
polymorphonuclear and mononuclear white cells of the mothers who gave 
birth to term AGA babies and term SGA babies. The mean plasma zinc level 
in the mother was low compared to controls but the zinc level in 
polymorphonuclear and mononuclear white cells were unchanged. 
Erythrocyte zinc did not correlate with the anthropometry of the baby.    
 
Study of serum zinc in neonates and their mothers in Shimla hills by              
Bahl L Chaudhuri L S Pathak R M 
35 
In this study, 159 mothers and their babies were included. The babies 
were classified in to term appropriate for gestational age, term small for 
gestational age, term large for gestational age, preterm appropriate for 
gestational age, preterm small for gestational age and preterm large for 
gestational age serum zinc level in both the maternal and cord blood samples 
were analysed. Serum zinc level in small for gestational age babies were 
significantly lower than the appropriate for gestational age babies in both the 
preterm and term groups. 
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Effect of zinc supplementation on pregnancy and infant outcome                  
Janet C King, Benjamin W Chaffee
 6 
 
This study is a meta analysis that included 20 randomised control 
trials. The trials were across the five continents from 1977 to 2008.The 
dosage range of zinc was from 5 to 50 mg/day. There was no significance 
between zinc supplementation and fetal growth parameters like birth weight, 
length or head circumference. There was a weak significance between zinc 
supplementation and preterm births. This might be due to a reduction in the 
incidence of maternal infection.  
 
A study on the effect of zinc supplementation prenatally on the birth 
weight –a meta analysis by Samson G. Gebreselassie 
7 
 
17 randomised controlled trials were analysed for the effect of zinc 
supplementation in mothers on the birth weight of the baby. Out of these, 
four studies were from United States of America, six from Asian countries, 
three from United Kingdom, three from the Latin Countries and only one 
from Africa. Thirteen RCTs found no association, three found a positive 
association and one found a negative association. This meta analysis found 
no association between maternal zinc supplementation and the birth weight. 
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Zinc supplementation for improving pregnancy and infant outcome by 
Mahomed K et al 
36 
 
The objective of this study was to find the effects of zinc 
supplementation in pregnancy on the maternal, fetal and neonatal outcomes. 
Seventeen randomised control trials were included in the study. Four studies 
were from United States of America, three from United Kingdom, two each 
from Indonesia and Peru, one trial each from Nepal, Pakistan, Bangladesh, 
Denmark, Chile and South Africa. Zinc supplementation resulted in a small 
significant reduction in the incidence of preterm births. But there was no 
significant association between maternal zinc supplementation and low birth 
weight. 
 
Birth weight and early neonatal outcome in infants born to 
malnourished pregnant women given multi micronutrient 
supplementation by R Chakrabarti et al 
37 
The study population was 350 pregnant women with body mass index 
<21 and the haemoglobin level between 7-9 g/dl.  They were divided into 
three groups. One group was supplemented with micronutrients from 20 
weeks till term, other group was supplemented from 20 to 30 weeks and the 
last group was given placebo. The birth weight was significantly higher in 
the group that was supplemented with micronutrients for a longer time. 
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Morbidity was also significantly decreased in the same group. Thus they 
concluded that micronutrient supplementation reduced the risk of low birth 
weight babies. 
 
Randomised control trial of the effect of zinc supplementation on 
pregnancy outcome in Bangladesh by Osendarp et al 
38 
 
It was a double blind placebo controlled trial in which 559 women 
were enrolled and the anthropometry of 410 new borns were measured. 
Serum zinc level was significantly high in the zinc supplemented group at 7 
months of gestation. There was no significance between zinc 
supplementation and birth weight, length or the head circumference. There 
was no difference in the incidence of prematurity.  
 
Maternal zinc supplementation in pregnant women of Peru by Caulfield 
LE et al 
39
 
1295 mothers were include in the trial. They received 60 mg of iron 
with or with out 15 mg zinc.At delivery 1016 remained in the study. 
Neonates’ anthropometric parameters were measured .This study found no 
difference between maternal zinc supplementation and birth weight or the 
gestational age of the baby. There was also no significance in the incidence 
of preterm or post term. There was no difference in the anthropometric 
measures like head circumference, crown heel length, chest circumference, 
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mid upper arm circumference, calf circumference and skin fold thickness 
between both the study groups.      
 
 
Effect of zinc supplementation on the pregnancy outcome by 
Goldenberg RL Tamura T Neggers Y et al 
40 
 
Around five hundred and eighty women were enrolled in study. Those 
who had low plasma zinc level at enrolment were randomized receive 25 mg 
of zinc from around 19 weeks of gestational age. One group received zinc in 
addition to a multivitamin tablet, another group received multivitamin tablet 
with a placebo. The babies of the zinc supplemented group had a 
significantly greater weight than the other group.    
 
 
Potential contribution of maternal zinc supplementation during 
pregnancy to maternal and child survival by Laura E Caulfield et al 
41 
 
This is a review of the effects of maternal zinc supplementation   on 
pregnancy and infant outcome. Mild to moderate zinc deficiency can be a 
relatively common one but the importance of the degree of deficiency of 
zinc is not well understood. The motive of this study was to bring the 
importance of zinc in to light as it may be related to fetal development and 
growth, adverse pregnancy outcomes. They concluded that more 
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supplementation trials are needed to assess the effect of zinc 
supplementation on the pregnancy and neonates’ outcome. 
 
Effect of prenatal zinc supplementation on the birth weight by Mahama 
Saaka et al 
42 
This study is a double blind randomised controlled study. Almost 600 
women in Ghana were enrolled .One group was assigned to receive 40 mg 
of zinc and 40 mg of iron as ferrous sulphate, the other group was assigned 
to receive only iron as ferrous sulphate. There was no significant difference 
in the mean birth weight of the two groups. The effects of prenatal zinc 
supplementation on the birth weight would have been masked by the effects 
of iron. They concluded that iron zinc supplementation was effective in 
increasing the weight of the neonate only among anemic mothers and not in 
mothers with good iron stores.  
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OBJECTIVES OF THE STUDY 
 
1. To study the serum zinc level in the cord blood of Term- small for   
gestational age babies. 
 
2. To determine whether low serum zinc level is an etiology for low birth 
weight in term small for gestational age babies and to assess their 
anthropometric outcome during the neonatal period.   
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MATERIALS AND METHODS 
 
STUDY DESIGN : Prospective case control study 
PLACE                 : Department of Paediatrics, 
Government Kilpauk Medical college Hospital 
STUDY PERIOD :  April 2011-June 2012 
STUDY POPULATION : 50 Term appropriate for gestational age babies 
and 50 Term small for gestational age babies born 
at Government Kilpauk medical college hospital. 
 
STUDY DEFINITION 
TERM BABY 
A baby whose gestational age falls between 37 completed weeks and 
41 6/7 weeks, that is 260-293 days. 
 
SMALL FOR GESTATIONAL AGE 
It is defined as a baby whose birth weight falls below the 10th centile 
in the Lubchenco growth chart. 
 
APPROPRIATE FOR GESTATIONAL AGE  
It is defined as a baby whose birth weight falls between 10th centile 
and 90th centile in the Lubchenco growth chart. 
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INCLUSION CRITERIA  
50 term appropriate for gestational age babies and 
50 term small for gestational age babies born at  
Government Kilpauk medical college hospital. 
 
EXCLUSION CRITERIA 
1. Babies with features of chromosomal abnormalities, intrauterine 
infection or with congenital malformations or those born of multiple 
gestation. 
2. Babies of mothers with severe malnutrition (body mass index<18.5), 
severe anaemia, diabetes mellitus, gestational diabetes, pregnancy 
induced hypertension, chronic illness, teratogenic drugs, placental 
abnormalities. 
3. Those babies who develop significant illness requiring admission in 
the neonatal intensive care unit. 
 
METHOD 
50 term-small for gestational age babies are selected based on the 
inclusion and exclusion criteria, their cord blood samples are collected from 
the placental end of the cord after obtaining consent from the baby’s mother 
or the father for determination of the serum zinc level. Cord blood samples 
are also collected from term-appropriate for gestational age babies with no 
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risk factors. Maternal history is noted. Gestational age is estimated by New 
Ballard scoring system. Birth weights are plotted against gestational age in 
Lubchenco growth charts to assess if they are small for gestational age or 
appropriate for gestational age. Physical examination of the babies are done. 
Babies requiring admission are taken to the neonatal intensive care unit. 
 
Well babies are given to the mothers for exclusive breast feeding. 
Mothers are advised to follow up at new born Out Patient Clinic every week. 
 
At every week of visit, anthropometry measurements are taken. 
Babies are weighed on a electronic weighing scale with the accuracy of 10 
grams. Length is measured by a infantometer accurate to 0.5 cm. Head 
circumference and chest circumference  are measured  by a non stretchable 
inch tape accurate to 0.1 cm .Mothers are also enquired regarding the 
babies‘ illness. Those babies who develop significant illness requiring 
admission in neonatal intensive care unit are excluded from the study. 
 
Serum zinc level is estimated by end point nitro paps dye binding 
colorimetric method. The data collected are analysed using SPSS version 
16.0. Qualitative data like parity, mode of delivery, sex of the baby are 
analysed by Pearson Chi square test. Quantitative data like maternal age, 
zinc level, weight, length and head circumference are analysed by student’t’ 
test. 
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LABORATORY ASSESSMENT OF ZINC 
In this study, zinc is estimated by end point nitro PAPS dye binding 
method. 
 
PRINCIPLE OF THE METHOD 
Nitro PAPS reacts with zinc in alkaline solution to form a purple 
coloured complex. Its absorbance is measured at 575 nm in a 
spectrophotometer. 
 
REAGENTS USED 
REAGENT –A 
Borate buffer 370 mM, pH 8.20, salicylaldoxime 12.5mM, diethyl 
dioxime 1.25 mM, surfactants and preservatives. 
 
REAGENT –B 
Nitro PAPS. 
 
REFERENCE VALUE 
Serum Zinc-70-150 micrograms/decilitre. 
 
LINEARITY 
The method is linear up to 1000micrograms/decilitre. 
 
SENSITIVITY/LIMIT OF DETECTION is 5 micrograms/decilitre. 
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OBSERVATION AND RESULTS 
 
TABLE – 1 PARITY - AGA VS SGA 
       
 
AGA SGA 
TOTAL 
NO. % NO. % 
PRIMI 22 44 27 54 49 
MULTI 28 56 23 46 51 
TOTAL 50 100 50 100 100 
 
PEARSON CHI SQUARE TEST 
 
P VALUE = 0.212   NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance in the 
parity of the mother between the AGA and SGA group. Thus maternal parity 
was comparable in both the groups. 
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TABLE – 2 : MODE OF DELIVERY AGA VS SGA 
 
 
AGA SGA  
 
TOTAL 
NO. % NO. % 
LN 26 52 27 54 53 
LSCS 24 48 23 46 47 
TOTAL 50 100 50 100 100 
 
PEARSON CHI SQUARE TEST 
 
P VALUE = 0.500   NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance in the 
mode of delivery between the AGA and SGA group. Thus both the groups 
were comparable in terms of mode of delivery of the baby. 
 
       
 
21
22
23
24
25
26
27
LN
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the study were delivered by labour naturale.
between the appropriate for gestational age
babies in terms of mode of delivery.
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TABLE – 3 : SEX OF THE BABY AGA VS SGA 
 
 
AGA SGA  
 
TOTAL 
NO. % NO. % 
MALE 30 60 24 48 54 
FEMALE 20 40 26 52 46 
TOTAL 50 100 50 100 100 
 
PEARSON CHI SQUARE TEST 
 
P VALUE = 0.324    NOT SIGNIFICANT 
 
The above tabulation shows that there was no significant difference in 
the sex of the baby between the AGA and SGA group. Thus both the groups 
were comparable in terms of sex of the baby. 
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TABLE - 4 : MATERNAL AGE - AGA VS SGA 
 
 
STUDENT ‘T’ TEST 
 
P VALUE =0.603                                 NOT SIGNIFICANT 
 
 
 The above tabulation shows that the mean maternal age in the AGA 
group was 24.56 and in the SGA group was 24.96. Thus there was no 
significant difference in the maternal age between AGA and SGA groups.  
 MATERNAL AGE (YEARS) 
 AGA SGA 
MEAN 24.56 24.96 
SD 3.357 4.262 
MINIMUM 19 19 
MAXIMUM 32 36 
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TABLE - 5 : CORD BLOOD ZINC-AGA VS SGA 
 
    
 
 
                  
 
 
 
 
STUDENT ‘T’ TEST 
 
P VALUE- 0.071    NOT SIGNIFICANT 
 
The above tabulation shows that the mean cord blood zinc level in 
AGA babies was 97.074 microgram/decilitre and in SGA babies was 92.472 
microgram/decilitre Thus there was no significant difference between the 
cord blood zinc level in AGA and SGA babies.  
  
 
ZINC 
LEVEL(MICROGRAM/DECILITRE) 
 AGA SGA 
MEAN 97.074 92.472 
SD 8.131 15.880 
MIN 85.3 58.7 
MAX 140.8 140.4 
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DESCRIPTIVE STATISTICS 
BOTH AGA AND SGA 
TABLE 6 
 
 
 
 
 
 
 
 
 
The above tabulation shows the mean cord blood zinc level, weight, 
length and head circumference of the entire study population. 
 MEAN SD 
ZINC(MICROGRAM/ 
DECILITRE) 
94.773 12.763 
WT(KG) 2.622 0.578 
LEN(CM) 49.040 1.629 
HC(CM) 36.045 0.818 
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TABLE - 7 CORRELATION BETWEEN ZINC AND 
ANTHROPOMETRY AT BIRTH 
 
 
             
        
 
 
 
 
 
 
 
The above tabular column shows that there is a weak positive 
correlation between zinc level and weight, length and head circumference at 
birth. 
 
But there is no statistical significance between cord blood zinc level 
and weight, length and head circumference at birth. 
 ZINC 
PARAMETERS p VALUE 
 
r VALUE 
WT 0.087 0.172 
LEN 0.328 0.099 
HC 0.621 0.050 
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DESCRIPTIVE STATISTICS 
TABLE - 8 ANTHROPOMETRY AT BIRTH - AGA Vs SGA 
 
 TABLE - 9 STUDENT T TEST 
 P VALUE SIGNIFICANCE 
WT 0.000 SIGNIFICANT 
LEN 0.874 NOT SIGNIFICANT 
HC 0.762 NOTSIGNIFICANT 
 
 
Table 8 shows that the mean birth weight of the appropriate for gestational 
age babies was 3.128 kg and the mean birth weight of the small for 
gestational babies was 2.116 kg. The mean length at birth in appropriate for 
 AGA SGA 
 WT(kg) LEN(cm) HC(cm) WT(kg) LEN(cm) HC(cm) 
MEAN 3.128 49.06 36.07 2.1168 49.014 36.02 
SD 0.346 1.854 0.557 0.183 1.388 1.020 
MIN 2.65 46.4 34.6 1.81 46.5 33.7 
MAX 3.71 52.5 36.8 2.42 52.1 37.8 
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gestational age babies was 49.06 cm and the mean length in small for 
gestational babies was 49.01 cm. The mean head circumference at birth in 
appropriate for gestational age babies was 36.07 cm and the mean head 
circumference at birth in small for gestational babies was 36.02 cm. 
 
There was no significant difference in the length and head 
circumference at birth in both appropriate for gestational age babies and 
small for gestational age babies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
                              DESCRIPTIVE STATISTICS 
TABLE – 9 : ANTHROPOMETRY AT 7 DAYS -AGA Vs SGA 
 
TABLE – 10 : STUDENT T TEST 
 P VALUE SIGNIFICANCE 
WT 0.000 SIGNIFICANT 
LEN 0.663 NOT SIGNIFICANT 
HC 0.000 SIGNIFICANT 
 
The above tabulation shows that the weight and head circumference in 
small for gestational age were significantly lower than the appropriate for 
gestational age at 7 days. There was no significant difference in length 
between AGA and SGA babies at 7 days.    
 AGA SGA 
 WT(kg) LEN(cm) HC(cm) WT(kg) LEN(cm) HC(cm) 
MEAN 3.106 49.80 36.548 2.127 49.936 35.856 
SD 0.344 1.812 0.553 0.204 1.189 0.762 
MIN 2.60 47 35 1.75 48 34.5 
MAX 3.65 53 37.2 2.5 52.8 37.4 
68 
 
DESCRIPTIVE STATISTICS 
TABLE - 11 ANTHROPOMETRY AT 14 DAYS - AGA Vs SGA 
 
TABLE - 12 STUDENT T TEST 
 
           
 
 
 
 
The above tabulation shows that the weight and head circumference in 
small for gestational age were significantly lower than the appropriate for 
gestational age at 14 days. There was no significant difference in length 
between AGA and SGA babies at 14 days.    
 AGA SGA 
 WT(kg) LEN(cm) HC(cm) WT(kg) LEN(cm) HC(cm) 
MEAN 3.221 50.362 37.026 2.3122 50.722 36.314 
SD 0.338 2.449 0.535 0.182 1.164 0.757 
MIN 2.71 38.4 35.5 1.98 48.6 34.9 
MAX 3.80 53.7 37.7 2.65 53.5 37.8 
 P VALUE SIGNIFICANCE 
WT 0.000 SIGNIFICANT 
LEN 0.350 NOT SIGNIFICANT 
HC 0.000 SIGNIFICANT 
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DESCRIPTIVE STATISTICS 
TABLE - 13 : ANTHROPOMETRY AT 21 DAYS-AGA Vs SGA 
 
TABLE - 14 : STUDENT T TEST 
 
           The above tabulation shows that the weight and head circumference 
in small for gestational age babies were significantly lower than the 
appropriate for gestational age at 21 days. There was no significant 
difference in length between AGA and SGA babies at 21 days.    
 
 AGA SGA 
 WT(kg) LEN(cm) HC(cm) WT(kg) LEN(cm) HC(cm) 
MEAN 3.461 51.36 51.36 2.534 51.52 36.78 
SD 0.330 1.696 1.696 0.193 1.124 0.746 
MIN 2.93 49 49 2.00 49 35 
MAX 4.01 55 55 2.86 54 38 
 P VALUE SIGNIFICANCE 
WT 0.000 SIGNIFICANT 
LEN 0.570 NOT SIGNIFICANT 
HC 0.000 SIGNIFICANT 
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DESCRIPTIVE STATISTICS 
TABLE – 15 : ANTHROPOMETRY AT 28 DAYS - AGA Vs SGA 
 
TABLE – 16 STUDENT T TEST 
 
The above tabulation shows that the weight and head circumference in 
small for gestational age were significantly lower than the appropriate for 
gestational age at 28 days. There was no significant difference in length 
between AGA and SGA babies at 28 days.    
 AGA SGA 
 WT(kg) LEN(cm) HC(cm) WT(kg) LEN(cm) HC(cm) 
MEAN 3.708 52.138 37.964 2.786 52.326 37.272 
SD 0.326 1.619 0.507 0.226 1.093 0.727 
MIN 3.24 49.2 36.5 2.21 50.2 35.9 
MAX 4.21 55.1 38.7 3.25 54.7 38.6 
 P VALUE SIGNIFICANCE 
WT 0.000 SIGNIFICANT 
LEN 0.498 NOT SIGNIFICANT 
HC 0.000 SIGNIFICANT 
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TABLE – 17 :ZINC Vs MATERNAL AGE IN SGA 
 
P VALUE-0.796                                         NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and maternal age in SGA babies. 
 AGE (YEARS) 
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 <20 21-25 26-30 >30 TOTAL 
55-65 0 1 1 1 3 
65.1-80 2 1 3 1 7 
80.1-95 3 8 4 3 18 
95.1-110 3 9 4 1 17 
110.1-125 0 2 1 0 3 
125.1-140 1 0 0 0 1 
>140 0 1 0 0 1 
 9 22 13 16 50 
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TABLE - 18 ZINC Vs PARITY OF THE MOTHER IN SGA 
 
PEARSON CHI SQUARE TEST 
 
P VALUE-0.329                                      NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and parity of the mother in small for gestational age babies. 
  
 
 PARITY  
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 PRIMI MULTI TOTAL 
55-65 2 1 3 
65.1-80 6 1 7 
80.1-95 7 11 18 
95.1-110 9 8 17 
110.1-125 2 1 3 
125.1-140 1 0 1 
>140 0 1 1 
  27 23 50 
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TABLE – 19 ZINC Vs MODE OF DELIVERY IN SGA 
 
  MODE OF DELIVERY  
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 LN LSCS TOTAL 
55-65 2 1 3 
65.1-80 4 3 7 
80.1-95 8 10 18 
95.1-110 11 6 17 
110.1-125 0 3 3 
125.1-140 1 0 1 
>140 1 0 1 
  27 23 50 
 
PEARSON CHI SQUARE TEST 
 
P VALUE-0.331                                      NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and mode of delivery in small for gestational age babies. 
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TABLE – 20 : ZINC Vs GESTATIONAL AGE IN SGA 
 
PEARSON CHI SQUARE TEST 
 
P VALUE-0.291                                         NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and gestational age in small for gestational age babies. 
  
  GESTATIONAL AGE  
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 
38 
WEEKS 
38-40 
WEEKS 
40 
WEEKS 
TOTAL 
55-65 0 3 0 3 
65.1-80 3 4 0 7 
80.1-95 6 7 5 18 
95.1-110 10 6 1 17 
110.1-125 2 1 0 3 
125.1-140 0 1 0 1 
>140 0 1 0 1 
  21 23 6 50 
75 
 
TABLE - 21 : ZINC Vs SEX OF THE BABY IN SGA 
 
 
 
PEARSON CHI SQUARE TEST 
 
P VALUE-0.566                                  NOT SIGNIFICANT 
 
 
The above tabulation shows that there was no significance between 
zinc and sex in small for gestational age babies. 
  
  
SEX OF THE 
BABY 
 
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 MALE FEMALE TOTAL 
55-65 2 1 3 
65.1-80 5 2 7 
80.1-95 7 11 18 
95.1-110 8 9 17 
110.1-125 2 1 3 
125.1-140 0 1 1 
>140 0 1 1 
  24 26 50 
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TABLE - 22 : ZINC Vs PONDERAL INDEX IN SGA 
  
PEARSON CHI SQUARE TEST 
 
VALUE-0.823                                       NOT SIGNIFICANT 
The above tabulation shows that there was no significance between 
zinc and Ponderal index in small for gestational age babies. 
 
 
PONDERAL 
INDEX 
 
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 1.6-1.7 1.8-1.9  
55-65 1 2 3 
65.1-80 4 3 7 
80.1-95 8 10 18 
95.1-110 7 10 17 
110.1-125 1 2 3 
125.1-140 1 0 1 
>140 0 1 1 
  27 23 50 
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TABLE – 23 ZINC Vs MATERNAL AGE IN AGA 
 
P VALUE=0.081                                           NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and maternal age in appropriate for gestational age babies.  
 
                                                   AGE (YEARS) 
Z
IN
C
  
(M
IC
R
O
G
/D
E
C
IL
IT
R
E
) 
 <20 21-25 26-30 >30 TOTAL 
55-65 0 0 0 0 0 
65.1-80 0 0 0 0 0 
80.1-95 1 11 7 1 20 
95.1-110 3 14 12 0 29 
110.1-125 0 0 0 0 0 
125.1-140 0 0 0 0 0 
>140 1 0 0 0 1 
 5 25 19 1 50 
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TABLE - 24 ZINC VS PARITY OF THE MOTHER IN AGA 
 
PEARSON CHI SQUARE TEST 
 
P VALUE=0.368         NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and parity in appropriate for gestational age babies. 
  
  PARITY  
Z
IN
C
 (
M
IC
R
O
G
R
A
M
/D
E
C
IL
IT
R
E
) 
 PRIMI MULTI TOTAL 
55-65 0 0 0 
65.1-80 0 0 0 
80.1-95 10 10 20 
95.1-110 11 18 28 
110.1-125 0 0 0 
125.1-140 0 0 0 
>140 1 0 1 
  22 28 50 
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TABLE - 25 ZINC Vs MODE OF DELIVERY IN AGA 
 
 
            MODE OF 
DELIVERY 
 
Z
IN
C
 (
M
IC
R
O
G
R
A
M
/D
E
C
IL
IT
R
E
) 
 LN LSCS TOTAL 
55-65 0 0 0 
65.1-80 0 0 0 
80.1-95 11 9 20 
95.1-110 14 15 29 
110.1-125 0 0 0 
125.1-140 0 0 0 
>140 1 0 1 
  26 24 50 
 
PEARSON CHI SQUARE TEST 
 
P VALUE=0.561                       NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and mode of delivery in appropriate for gestational age babies. 
80 
 
TABLE - 26 : ZINC VS SEX OF THE BABY IN AGA 
 
  
SEX OF THE 
BABY 
 
Z
IN
C
 (
M
IC
R
O
G
R
A
M
/D
E
C
IL
IT
R
E
) 
 MALE FEMALE TOTAL 
55-65 0 0 0 
65.1-80 0 0 0 
80.1-95 9 11 20 
95.1-110 20 9 29 
110.1-125 0 0 0 
125.1-140 0 0 0 
>140 1 0 1 
  30 20 50 
 
PEARSON CHI SQUARE TEST 
 
P VALUE=0.173                                   NOT SIGNIFICANT 
 
The above tabulation shows that there was no significance between 
zinc and sex of the baby in appropriate for gestational age babies. 
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DISCUSSION 
 
Infant mortality rate of India is 48 per 1000 live births which is 
mainly contributed by the high neonatal mortality rate of 32 per 1000 live 
births1. India contributes around 25% of world’s neonatal deaths8. Thus one 
fourth of the world’s total neonatal deaths occur in India. 
 
In 2008, around 75% of the deaths in children less than 5 years 
occurred in 18 countries, out of this 40% occurred in three countries- 
Nigeria, India and Democratic republic of Congo8. Around 18 million babies 
are born as low birth weight in the world 8. Low birth weight including 
preterm accounts for around 60-80% of the total neonatal deaths. Fifty 
percentage of these babies are born in South Asia8. Incidence of low birth 
weight in India is 28% 1.The incidence of low birth weight in sub-Saharan 
Africa is around 14% which is lower than ours.  Thus efforts are on the way 
to reduce the incidence of low birth weight in India. 
 
One of the most important causes of low birth weight in India is 
maternal malnutrition. While a lot of importance is being given to protein 
and energy deficits, micronutrients other than iron are often forgotten. 
Though they are needed only in small quantity, they have several vital 
functions in our human body. As their requirements are small, their 
adequacy have to be checked carefully and moreover many of the trace 
82 
 
elements have interactions with each other. Thus their needs have to be 
adequately met with a concern over their interactions and toxicity.  
 
Among the several micronutrients, Iron stands first whose importance 
have been extensively studied and practised. Next lies zinc whose 
importance is slowly brought in to light by several research trials and 
studies.  
 
Term-small for gestational age babies are more common than preterm 
babies in our country. Thus the role of zinc in term –small for gestational 
age babies have to be studied. 
 
In this study,  cord blood zinc level of fifty term appropriate for 
gestational age  babies and fifty term small for gestational age babies have 
been analysed .The maternal and neonatal parameters of both the groups 
have been analysed. Further, the association between zinc and the other 
parameters have also been analysed in both the groups. 
 
The aim was to study the association between zinc and birth weight in 
term small for gestational age babies and if low, whether low zinc level 
could be a cause for low birth weight in term small for gestational age 
babies. As there are multiple causes for low birth weight, many factors 
leading to low birth weight have been excluded. 
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In this study, the mean cord blood zinc level in term appropriate for 
gestational age babies was 97.074 micrograms/decilitre and the mean cord 
blood zinc level in term small for gestational age babies was 92.472 
micrograms/decilitre. There was no statistically significant difference in zinc 
level between both the groups. 
 
In a study by Elizabeth et al10, the mean zinc level was 70.25 + 24.59 
micrograms/decliltre in term appropriate for gestational age babies and 
78.09 + 18.39 micrograms /decilitre in small for gestational age babies. Thus 
in our study the mean zinc level in both small for gestational age and 
appropriate for gestational age babies were higher than the above study. 
 
However mean zinc value in appropriate for gestational age babies in 
our study was lower when compared with the studies done by Frkovic et al25 
(118+0.21 microgram/dl), Croatia and Awadallah et al16 (114+23 
microgram/dl), Jordan. 
 
Zinc level in our study was comparable with the study done by 
Meadows et al11, (94 micrograms/dl in appropriate for gestational age and 91 
micrograms/dl in SGA), London. 
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According to a study by Iqbal et al15 from Bangladesh, the mean zinc 
level in the group weighing from 2600 grams to 3000 grams was 83+/-0.43 
micrograms /dl and in group of babies ranging from 37-39 weeks was 79 
micrograms/dl.  
 
In our study both the appropriate for gestational age and small for 
gestational age groups were comparable in the qualitative data like parity of 
the mother (p>0.05), mode of delivery (p>0.05) and the sex of the baby 
(p>0.05). 
 
There was no significance in maternal age between both the groups. 
(p>0.05). The mean age of the mothers in appropriate for gestational age 
group was   24.56 and in SGA group was 24.96. 
 
There was a weak positive correlation between the serum zinc level 
and the anthropometric parameters at birth (weight, length and head 
circumference) in both the groups but there was no statistical significance 
between the zinc level and anthropometric parameters at birth. 
 
Thus there was no statistical significance between birth weight and 
zinc levels. This is in accordance with the Indian studies done by Srivastava 
et al12, George et al23, Chitra Upadhyaya et al33. The same inference was 
obtained in studies of other countries too. Meadows et al11, Islam et al13, Lao 
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et al14, Iqbal et al15, Watanabe et al18, Doszpod et al24, Bro s et al28 and 
several other studies. 
 
The results obtained in this study also agrees with several randomised 
controlled trials of maternal zinc supplementation and their effect on the 
birth weight. Most of these trials have concluded that maternal zinc 
supplementation did not have a significant effect on the birth weight of the 
babies. (Osendarp et al 38, Caulfield et al39). 
 
But the trial done by Goldenberg et al40 is contradictory to our study 
results. This trial concluded that the mean birth weight increased in mothers 
who were supplemented with zinc. Results obtained in the studies done by 
Elizabeth et al, Jeswani et al also contradict our study results, low zinc level 
was associated with low birth weight in these studies. 
 
In this study, the mean birth weight of the appropriate for gestational 
age babies was 3.128kg and the mean birth weight of the small for 
gestational age babies was 2.116 kg. There was no significant difference in 
the length and head circumference at birth in both appropriate for gestational 
age and small for gestational age groups.  
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The weight gain and the increase in the head circumference of the 
small for gestational babies were significantly lower than the appropriate for 
gestational age babies at all four weeks of follow up.  There was no 
significant difference in the increase in the length of the babies in both the 
groups at all four weeks of follow up. 
 
In this study there was no significance between the serum zinc level 
and the maternal age, parity, mode of delivery and the sex of the baby in 
both appropriate for gestational age and small for gestational age groups. 
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CONCLUSION 
 
 This study concludes that there is no statistical significance in the cord 
blood zinc level between the term-appropriate for gestational age 
babies and the term –small for gestational age babies.  
 
 Cord blood zinc level has no significance with the birth weight of the 
baby.  
 
 Thus we conclude that zinc deficiency alone cannot contribute to low 
birth weight. 
 
 Further studies are needed to assess the role of zinc and other trace 
elements in neonates as zinc may affect the bioavailability of other 
trace elements. 
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PROFORMA 
1. Name 
2. Age 
3. IP No. 
4. Address 
5. Phone no. 
6. Last menstrual period 
7. Expected date of delivery 
8. Details of admission 
9. Marital history 
10. Obstetric history 
11. Past history-chronic illness, drug intake 
12. Maternal height 
13. Maternal weight 
14. Body mass index 
15. Blood group 
16. Hemoglobin 
17. HIV 
     VDRL 
      HBsAg 
18. Details of delivery :labour naturale /caesarean section 
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19. Baby details. 
Birth weight 
Length 
Head circumference 
Ponderal index 
Gestational age 
Classification according to Lubchenco chart-AGA/SGA/LGA 
Sex of the baby  
Disc no. 
Apgar 
Any congenital anomaly 
Dysmorphic features 
Systemic examination 
20. Cord blood zinc level 
 
21. At 7 days-weight 
length 
head circumference 
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22. At 14 days- weight 
length 
head circumference 
23. At 21 days- weight 
length 
head circumference 
24. At 28 days - weight 
length 
head circumference 
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LUBCHENCO INTRA UTERINE GROWTH CHART 
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LIST OF ABBREVIATIONS 
 
AGA  -  Appropriate for gestational age 
SGA   -  Small for gestational age 
IUGR  -  Intrauterine growth retardation 
TORCH -  Toxoplasmosis, Rubella, Cytomegalovirus, Herpes, HIV. 
WT  -  weight 
LEN  -  length 
HC  -  head circumference 
LN  -  labour naturale 
LSCS  -  lower segment caesarean section 
PRIMI  -  primi para  
MULTI  -  multi para  
Cm  -  centimetre 
kg  - kilogram 
dl  -  decilitre 
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Ethical Committee Certificate 
102 
 
103 
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CONSENT FORM   
xg;Gjy; gbtk; ; ; ;; ; ;; ; ;  
Ma;T nra;ag;gLk; jiyg;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  
epiwkhj Fiwe;j vil gr;rpsq; Foe;ijfspd; njhg;Gs;nfhb uj;jj;jpy; [pq;fpd; 
(Jj;jehfk;) msT     
Foe;ijfs; kw;Wk; gr;rpsq; Foe;ijfs; eyj;Jiw  
fPog;ghf;fk; kUj;Jtf; fy;Y}up kw;Wk; kUj;Jtkid  
nrd;id-10.      : 
gq;F ngWgthpd; ngaH    : 
gq;F ngWgthpd; taJ    : 
gq;F ngWgthpd; vz;    : 
Foe;ijapd; tptuk; - Mz;/ ngz;   : 
vil   : 
gq;F ngWgtH ,jid (√) Fwpf;fTk;. 
 NkNy Fwpg;gpl;Ls;s kUj;Jt Ma;tpd; tptuq;fs; vdf;F 
tpsf;fg;gl;lJ. vd;Dila re;Njfq;fis Nfl;fTk; mjw;fhd 
jFe;j tpsf;fq;fis Nfl;f tha;g;gspf;fg;gl;Ls;sJ vd mwpe;J 
nfhz;Nld;. 
 
 ehDk;> vd; Foe;ijAk; gq;Nfw;f rk;kjpf;fpNwd;. ,J ahUila 
tw;GWj;jYkpd;wp jd;dpr;irahf $Wk; KbT> ve;j 
fhuzj;jpdhNyh ve;j rl;lrpf;fYf;Fk; cl;glhky; ehd; 
,t;tha;tpy; ,Ue;J tpyfpf; nfhs;syhk; vd;Wk; mwpe;J 
nfhz;Nld;. 
 
 ,e;j Ma;T rk;ge;jkhfNth mij rhHe;J NkYk; Ma;T 
Nkw;nfhs;Sk; NghJk; ,e;j Ma;tpy; gq;F ngWk; kUj;JtH 
vd;Dila kUj;Jt mwpf;iffis ghh;g;gjw;F vd; mDkjp 
Njitapy;iy vd mwpe;J nfhs;fpNwd;. 
 
 ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah KbitNah 
gad;gLj;jpf; nfhs;s kWf;fkhl;Nld;. 
 
 ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd;. ,e;j Ma;it 
Nkw;nfhs;Sk; kUj;Jt mzpf;F cd;ikAld; ,Ug;Ngd; vd;Wk; 
cWjpaspf;fpNwd;. 
 
 ,e;j Ma;tpy; xUKiw 2.5 kp ,uj;jk; njhg;Gs; nfhbapd; 
eQ;Rg;igapd; Kidapy; ,Ue;J ghpNrhjidf;fhf vLj;jf; 
nfhs;sg;gLk; vd;gij mwpNtd;. 
gq;Nfw;gthpd; ifnahg;gk;____________ ,lk;_________________         
Njjp__________________  
gq;Nfw;gtupd; ngaH kw;Wk; tpyhrk;  
 
rhl;rpahshpd; ifnahg;gk; 
,lk;_____________ Njjp___________________  
rhl;rpahshpd; ngaH kw;Wk; tpyhrk; 
Ma;thshpd; ifnahg;gk; 
,lk;_____________ Njjp____________________ 
Ma;thshpd; ngaH__________________________   
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KEY TO MASTER CHART  
MOD  - Mode of Delivery  
WT _ 0  -  Birth Weight    
LEN _0  -  Length at Birth  
HC_0  -  Head Circumference at Birth  
GEAGE_0  -  Gestational age  
PI_0  -  Ponderal Index  
LN   -  Labour Naturale  
LSCS  -  Lower Segment Caesarean Section   
WT_7 -  Weight at 7 Days  
WT _14  -  Weight at 14 Days 
WT_21 -  Weight at 21 Days 
WT_28  -  Weight at 28 Days 
LEN_7  -  Length at 7 Days   
LEN_14  -  Length at 14 Days  
LEN_21  -  Length at 21 Days 
LEN_28  -  Length at 28 Days 
HC_7  -  Head Circumference at 7 Days  
HC_14  -  Head Circumference at 14 Days  
HC_21  -  Head Circumference at 21 Days 
HC_28  -  Head Circumference at 28 Days 
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MASTER CHART 
TERM - SMALL FOR GESTATIONAL AGE BABIES  
SL. No NAME AGE PARITY MOD WT_0 LEN_0 HC_0 GEAGE_0 SEX PI_0 ZINC_0 
1 B/o MAHALAKSHMI 25 M LN 2.29 50.2 35.6 38-40 FEMALE 1.8 140.4 
2 B/o GEETHA SALIM 35 M LN 2.41 50.2 36.2 40 FEMALE 1.9 87.0 
3 B/o MADHAVI 20 P LN 2.25 50.9 37.1 38-40 FEMALE 1.7 94.5 
4 B/o SUMATHY 25 M LSCS 1.81 46.5 34.6 38 FEMALE 1.8 96.0 
5 B/o SARALA 20 P LSCS 2.11 49.8 35.5 38 MALE 1.7 75.4 
6 B/o USHA 27 M LSCS 2.33 49.1 36.9 38-40 MALE 1.9 91.9 
7 B/o MAHALAKSHMI 32 M LN 2.31 50.4 37.5 38-40 FEMALE 1.8 102.3 
8 B/o LATHA 25 M LSCS 2.01 49.0 36.3 38 FEMALE 1.7 89.2 
9 B/o JEYALAKSHMI 19 P LN 2.25 50.9 35.2 38-40 FEMALE 1.7 128.4 
10 B/o THAVAMANI 20 P LSCS 2.00 50.0 37.5 38 FEMALE 1.6 91.0 
11 B/o GEETHA KUMAR 36 P LN 2.42 51.2 37.5 40 MALE 1.8 91.8 
12 B/o SANTHANA MARI 25 M LSCS 2.41 52.1 37.3 40 MALE 1.7 93.1 
13 B/o VIJI 22 P LSCS 2.40 50.1 36.9 40 FEMALE 1.9 101.3 
14 B/o GANDHIMATHY 21 P LSCS 2.36 49.3 36.1 40 MALE 1.9 85.8 
15 B/o REVATHY 25 M LSCS 2.34 51.6 37.8 38-40 MALE 1.7 84.8 
16 B/o GANGA DEVI 24 M LSCS 2.19 48.6 35.7 38-40 MALE 1.9 87.7 
17 B/o SEETHA 22 P LN 1.93 47.5 33.7 38 FEMALE 1.8 85.3 
18 B/o NADHIYA 21 P LN 1.92 48.3 34.1 38 FEMALE 1.7 96.0 
19 B/o DEIVARATCHAGI 32 M LSCS 2.22 48.7 35.7 38 FEMALE 1.9 86.0 
20 B/o AARTHY 19 P LN 1.83 47.3 36.5 38 FEMALE 1.7 95.8 
21 B/o VEERASELVI 19 P LSCS 2.04 49.3 36.7 38 MALE 1.7 79.7 
22 B/o KAROLINE 20 M LN 2.10 48.8 37.1 38-40 FEMALE 1.8 91.3 
23 B/o CHITHRA 32 P LSCS 2.12 49.9 35.8 38-40 FEMALE 1.7 78.8 
24 B/o SUMITHRA 27 P LN 2.11 48.0 35.6 38-40 FEMALE 1.9 73.4 
25 B/o SANKARI 25 P LN 1.82 46.5 34.6 38-40 MALE 1.8 70.4 
26 B/o SANDHYA 26 M LN 1.81 47.3 34.4 38 MALE 1.7 70.0 
27 B/o NEELA VENI 24 M LN 2.10 49.8 35.5 38-40 FEMALE 1.7 62.1 
28 B/o JAYAMALINI 27 P LN 1.92 47.4 35.0 38-40 MALE 1.8 72.1 
29 B/o RADHIKA 29 P LN 2.32 49.6 36.6 38-40 MALE 1.9 58.7 
30 B/o ARCHANA 31 P LSCS 2.17 48.5 37.1 38-40 MALE 1.9 61.1 
31 B/o MANGAI 26 M LSCS 2.05 48.4 36.1 38 FEMALE 1.8 91.6 
32 B/o DEVI 25 P LN 1.83 47.5 36.6 38-40 FEMALE 1.7 82.5 
33 B/o JEYA 20 M LSCS 2.09 49.7 37.0 38-40 MALE 1.7 98.1 
34 B/o GOWTHAMI 21 P LN 2.10 49.8 36.3 38-40 MALE 1.7 101.2 
35 B/o SEETHA 22 M LN 2.08 48.2 35.1 38 FEMALE 1.8 98.2 
36 B/o SENTHAMARAI 28 M LSCS 1.81 46.5 34.2 38 FEMALE 1.8 99.0 
37 B/o RUBINI 29 P LSCS 2.23 49.8 35.6 38 MALE 1.8 101.4 
38 B/o GEETHA 30 M LSCS 2.26 46.8 36.6 38-40 MALE 1.7 85.6 
39 B/o TAMILARASI 24 P LN 2.41 49.9 37.5 40 FEMALE 1.9 91.7 
40 B/o RAMYA 26 M LN 1.88 47.9 35.5 38 FEMALE 1.7 102.6 
41 B/o SATHYA 20 P LN 2.07 47.7 36.6 38-40 MALE 1.9 104.3 
42 B/o SOUNDARYA 29 M LSCS 2.08 48.7 35.5 38 FEMALE 1.8 111.7 
43 B/o KAMALA 25 P LN 2.11 49.8 36.4 38 MALE 1.7 102.4 
44 B/o SELVI 27 M LN 1.97 47.8 36.0 38 MALE 1.8 103.1 
45 B/o DEVI 23 P LSCS 2.13 50.0 36.7 38 MALE 1.7 124.1 
46 B/o AMUDHA 21 P LSCS 2.06 48.5 35.3 38-40 MALE 1.8 111.2 
47 B/o VALARMATHY 28 M LN 1.84 47.6 34.1 38 FEMALE 1.7 92.6 
48 B/o VENNILA 23 M LN 2.23 49.8 35.6 38 FEMALE 1.8 95.6 
49 B/o JEYANTHI 21 P LN 2.15 48.3 36.7 38-40 MALE 1.9 106.3 
50 B/o SUMATHY 25 P LSCS 2.16 51.2 35.5 38-40 MALE 1.6 99.1 
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   TERM - APPROPRIATE FOR GESTATIONAL AGE BABIES  
SL. 
No 
NAME AGE PARITY MOD 
WT_
0 
LEN_0 HC_0 GEAGE_0 SEX ZINC_0 
1 B/o STELLA 28 M LSCS 3.41 51.2 36.6 38-40 MALE 95.4 
2 B/o VIJAYALAKSHMI 28 M LSCS 3.32 50.2 36.4 38-40 MALE 106.2 
3 B/o NALINI 28 M LSCS 3.08 48.6 35.6 38-40 MALE 102.8 
4 B/o SARASWATHY 23 M LSCS 3.71 52.4 35.5 38-40 FEMALE 104.2 
5 B/o BHUVANESHWARI 22 P LN 2.92 48.0 36.5 38-40 MALE 108.2 
6 B/o PRIYA 20 P LSCS 2.75 47.1 36.5 38-40 MALE 101.5 
7 B/o DHANALAKSHMI 23 M LN 3.32 50.1 35.7 38-40 FEMALE 99.2 
8 B/o PRAMILA 21 P LN 3.60 52.1 36.7 38-40 FEMALE 100.3 
9 B/o RAMANI 19 P LN 2.86 47.6 36.8 38-40 MAL E 140.8 
10 B/o PREMA 30 P LSCS 2.83 46.4 36.2 38-40 FEMALE 102.2 
11 B/o KANCHANA 22 P LSCS 3.61 51.5 36.8 38-40 FEMALE 96.2 
12 B/o SANGEETHA 24 M LN 2.75 47.1 35.9 38-40 MALE 93.4 
13 B/o VISALATCHI 26 M LSCS 2.80 47.6 35.6 38-40 MALE 105.3 
14 B/o VIJAYALAKSHMI 22 P LN 3.01 48.7 34.6 38-40 MALE 101.3 
15 B/o AGASTHIA 21 P LSCS 3.23 48.8 36.6 38-40 FEMALE 85.3 
16 B/o SURYA 23 P LN 2.74 47.0 36.4 38-40 MALE 99.1 
17 B/o DEEPA 24 M LN 3.60 51.6 36.1 38-40 FEMALE 101.1 
18 B/o SARANYA 22 M LN 2.65 46.5 35.6 38-40 MALE 98.6 
19 B/o DEVI 28 M LSCS 2.81 47.1 36.5 38-40 MALE 97.2 
20 B/o ELLAMMMA 32 P LN 3.41 50.6 35.3 38-40 MALE 93.4 
21 B/o RAASATHI 19 P LSCS 2.68 47.1 36.5 38-40 FEMALE 92.5 
22 B/o VAIDEGI 23 P LN 2.92 48.8 36.2 38-40 MALE 93.2 
23 B/o SAVITHRI 30 P LN 2.93 48.1 36.5 38-40 MALE 101.4 
24 B/o FARHANA 19 P LN 2.74 47.2 36.5 38-40 FEMALE 99.2 
25 B/o AMMANI 29 M LN 3.70 51.4 36.5 38-40 MALE 99.6 
26 B/o KAVITHA 29 M LN 2.89 48.0 36.5 38-40 MALE 95.2 
27 B/o PREETHA 27 P LSCS 3.49 51.2 35.8 38-40 FEMALE 93.6 
28 B/o SUMATHY 28 M LSCS 2.89 47.1 36.6 38-40 FEMALE 92.4 
29 B/o DEEPA 26 P LN 2.76 47.1 36.5 38-40 MALE 94.3 
30 B/o KAVITHA 27 M LSCS 3.65 52.1 35.4 38-40 FEMALE 94.2 
31 B/o DEVI 23 P LSCS 2.84 48.2 35.9 38-40 MALE 96.5 
32 B/o SARANYA 20 P LN 3.21 50.1 35.6 38-40 FEMALE 100.1 
33 B/o SANGEETHA 29 M LSCS 3.49 51.0 36.7 38-40 MALE 95.2 
34 B/o RAMYA 22 M LN 3.58 51.5 35.4 38-40 MALE 98.4 
35 B/o REVATHY 21 M LSCS 3.02 48.6 35.6 38-40 MALE 97.5 
36 B/o SEETHA 30 M LSCS 3.11 48.7 36.5 38-40 FEMALE 96.4 
37 B/o NADHIYA 24 M LSCS 3.42 50.0 35.2 38-40 MALE 95.2 
38 B/o USHA 28 M LN 2.92 47.9 35.0 38-40 MALE 85.9 
39 B/o SUMATHY 23 P LN 2.83 47.0 34.9 38-40 FEMALE 89.2 
40 B/o LATHA 21 M LSCS 2.74 47.1 35.6 38-40 MALE 96.4 
41 B/o LAKSHMI 25 M LSCS 3.14 48.7 36.2 38-40 FEMALE 89.3 
42 B/o SHALINI 26 M LN 3.52 51.1 36.7 38-40 MALE 98.2 
43 B/o KAMALA 24 M LN 3.68 52.5 36.3 38-40 FEMALE 91.6 
44 B/o REVATHY 23 P LSCS 3.04 48.4 35.7 38-40 MALE 92.3 
45 B/o SARITHA 21 M LN 2.78 47.2 36.3 38-40 FEMALE 89.6 
46 B/o GEETHA 24 M LN 2.89 48.1 35.7 38-40 FEMALE 91.5 
47 B/o PRIYA 27 P LSCS 3.63 49.5 36.6 38-40 MALE 93.4 
48 B/o SARANYA 26 M LN 3.24 50.6 35.7 38-40 FEMALE 91.2 
49 B/o NADHIYA 25 M LSCS 3.59 51.5 36.5 38-40 MALE 90.3 
50 B/o LATHA 23 P LN 2.71 47.3 36.5 38-40 MALE 88.2 
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TERM - SMALL FOR GESTATIONAL AGE BABIES - WEIGHT   
SL. No NAME WT_7 WT_14 WT_21 WT_28 
1 B/o MAHALAKSHMI 2.25 2.41 2.58 2.81 
2 B/o GEETHA SALIM 2.36 2.42 2.65 2.90 
3 B/o MADHAVI 2.20 2.51 2.76 3.10 
4 B/o SUMATHY 1.75 2.01 2.21 2.55 
5 B/o SARALA 2.10 2.31 2.54 2.81 
6 B/o USHA 2.35 2.45 2.69 3.02 
7 B/o MAHALAKSHMI 2.40 2.61 2.78 3.15 
8 B/o LATHA 2.00 2.21 2.38 2.66 
9 B/o JEYALAKSHMI 2.30 2.32 2.53 2.85 
10 B/o THAVAMANI 1.90 2.20 2.37 2.56 
11 B/o GEETHA KUMAR 2.45 2.59 2.82 3.14 
12 B/o SANTHANA MARI 2.50 2.65 2.86 3.24 
13 B/o VIJI 2.35 2.48 2.75 3.08 
14 B/o GANDHIMATHY 2.40 2.45 2.74 3.11 
15 B/o REVATHY 2.41 2.56 2.77 2.98 
16 B/o GANGA DEVI 2.25 2.46 2.67 2.92 
17 B/o SEETHA 1.90 2.11 2.32 2.53 
18 B/o NADHIYA 1.89 2.16 2.36 2.63 
19 B/o DEIVARATCHAGI 2.25 2.44 2.65 2.90 
20 B/o AARTHY 1.80 1.98 2.21 2.46 
21 B/o VEERASELVI 2.00 2.13 2.34 2.56 
22 B/o KAROLINE 2.13 2.23 2.45 2.67 
23 B/o CHITHRA 2.15 2.37 2.61 2.84 
24 B/o SUMITHRA 2.16 2.36 2.58 2.81 
25 B/o SANKARI 1.80 2.00 2.23 2.51 
26 B/o SANDHYA 1.80 2.10 2.31 2.54 
27 B/o NEELA VENI 2.15 2.36 2.57 2.71 
28 B/o JAYAMALINI 1.89 2.00 2.34 2.62 
29 B/o RADHIKA 2.20 2.41 2.61 2.73 
30 B/o ARCHANA 2.20 2.31 2.51 2.76 
31 B/o MANGAI 2.10 2.20 2.44 2.68 
32 B/o DEVI 1.87 2.10 2.00 2.21 
33 B/o JEYA 2.12 2.34 2.66 2.91 
34 B/o GOWTHAMI 2.30 2.23 2.53 2.76 
35 B/o SEETHA 2.12 2.23 2.54 2.84 
36 B/o SENTHAMARAI 1.80 2.00 2.28 2.52 
37 B/o RUBINI 2.25 2.42 2.65 2.86 
38 B/o GEETHA 2.40 2.61 2.84 3.25 
39 B/o TAMILARASI 2.40 2.61 2.82 3.15 
40 B/o RAMYA 1.86 2.10 2.32 2.45 
41 B/o SATHYA 2.00 2.21 2.42 2.66 
42 B/o SOUNDARYA 2.10 2.34 2.55 2.71 
43 B/o KAMALA 2.13 2.30 2.52 2.74 
44 B/o SELVI 1.91 2.20 2.45 2.67 
45 B/o DEVI 2.15 2.33 2.57 2.78 
46 B/o AMUDHA 2.10 2.32 2.53 2.72 
47 B/o VALARMATHY 1.82 2.10 2.34 2.54 
48 B/o VENNILA 2.21 2.44 2.66 2.84 
49 B/o JEYANTHI 2.20 2.42 2.64 2.87 
50 B/o SUMATHY 2.25 2.51 2.75 3.01 
109 
 
TERM-APPROPRIATE FOR GESTATIONAL AGE BABIES-WEIGHT   
SL. 
No 
NAME WT_7 WT_14 WT_21 WT_28 
1 B/o STELLA 3.40 3.45 3.64 3.82 
2 B/o VIJAYALAKSHMI 3.31 3.42 3.64 3.85 
3 B/o NALINI 3.10 3.25 3.46 3.67 
4 B/o SARASWATHY 3.65 3.80 4.01 4.18 
5 B/o BHUVANESHWARI 2.90 3.00 3.18 3.41 
6 B/o PRIYA 2.70 2.80 3.10 3.31 
7 B/o DHANALAKSHMI 3.31 3.33 3.54 3.78 
8 B/o PRAMILA 3.58 3.70 3.91 4.20 
9 B/o RAMANI 2.86 3.00 3.24 3.45 
10 B/o PREMA 2.80 3.00 3.24 3.46 
11 B/o KANCHANA 3.57 3.70 3.91 4.19 
12 B/o SANGEETHA 2.71 2.90 3.24 3.65 
13 B/o VISALATCHI 2.75 2.92 3.23 3.48 
14 B/o VIJAYALAKSHMI 3.45 3.52 3.74 3.96 
15 B/o AGASTHIA 3.25 3.40 3.64 3.86 
16 B/o SURYA 2.70 2.81 3.05 3.32 
17 B/o DEEPA 3.55 3.71 3.96 4.21 
18 B/o SARANYA 2.62 2.72 2.98 3.24 
19 B/o DEVI 2.80 3.00 3.25 3.46 
20 B/o ELLAMMMA 3.42 3.54 3.85 4.10 
21 B/o RAASATHI 2.60 2.71 2.93 3.30 
22 B/o VAIDEGI 2.90 3.02 3.27 3.58 
23 B/o SAVITHRI 2.90 3.05 3.34 3.59 
24 B/o FARHANA 2.73 2.90 3.23 3.45 
25 B/o AMMANI 3.65 3.72 3.91 4.20 
26 B/o KAVITHA 2.91 3.00 3.21 3.42 
27 B/o PREETHA 3.42 3.53 3.79 3.99 
28 B/o SUMATHY 2.85 3.02 3.23 3.62 
29 B/o DEEPA 2.70 2.82 3.02 3.25 
30 B/o KAVITHA 3.60 3.71 3.93 4.19 
31 B/o DEVI 2.80 2.90 3.22 3.45 
32 B/o SARANYA 3.19 3.26 3.47 3.68 
33 B/o SANGEETHA 3.42 3.51 3.72 3.94 
34 B/o RAMYA 3.52 3.61 3.84 4.10 
35 B/o REVATHY 3.00 3.10 3.35 3.68 
36 B/o SEETHA 3.10 3.21 3.52 3.73 
37 B/o NADHIYA 3.40 3.51 3.73 3.95 
38 B/o USHA 2.90 3.01 3.25 3.46 
39 B/o SUMATHY 2.81 2.92 3.15 3.36 
40 B/o LATHA 2.72 2.80 3.01 3.26 
41 B/o LAKSHMI 3.10 3.21 3.52 3.76 
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42 B/o SHALINI 3.50 3.62 3.83 4.10 
43 B/o KAMALA 3.60 3.71 3.91 4.18 
44 B/o REVATHY 3.00 3.10 3.35 3.63 
45 B/o SARITHA 2.72 2.81 3.00 3.26 
46 B/o GEETHA 2.85 2.91 3.19 3.41 
47 B/o PRIYA 3.60 3.72 3.96 4.20 
48 B/o SARANYA 3.20 3.27 3.48 3.69 
49 B/o NADHIYA 3.50 3.62 3.88 4.12 
50 B/o LATHA 2.70 2.81 3.00 3.25 
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TERM - SMALL FOR GESTATIONAL AGE BABIES - LENGTH   
SL. 
No 
NAME LEN_7 LEN_14 LEN_21 LEN_28 
1 B/o MAHALAKSHMI 50.8 51.4 52 52.8 
2 B/o GEETHA SALIM 50.7 51.5 52 53.2 
3 B/o MADHAVI 51.6 52.3 53 54.1 
4 B/o SUMATHY 49.1 50.2 51 51.9 
5 B/o SARALA 50.6 51.5 52 53.1 
6 B/o USHA 50.0 50.9 52 52.4 
7 B/o MAHALAKSHMI 51.1 52.0 53 53.6 
8 B/o LATHA 49.7 50.3 51 51.8 
9 B/o JEYALAKSHMI 51.4 52.1 53 53.6 
10 B/o THAVAMANI 50.7 51.2 52 52.8 
11 B/o GEETHA KUMAR 51.7 52.4 53 53.8 
12 B/o SANTHANA MARI 52.8 53.5 54 54.7 
13 B/o VIJI 50.8 51.6 52 53.1 
14 B/o GANDHIMATHY 50.1 51.0 52 52.6 
15 B/o REVATHY 52.2 52.9 54 54.2 
16 B/o GANGA DEVI 49.6 50.5 52 52.3 
17 B/o SEETHA 48.2 48.7 49 50.4 
18 B/o NADHIYA 49.1 50.4 51 52.1 
19 B/o DEIVARATCHAGI 49.4 50.0 51 51.5 
20 B/o AARTHY 48.0 48.6 50 50.4 
21 B/o VEERASELVI 49.9 50.5 51 52.0 
22 B/o KAROLINE 49.6 50.2 51 51.9 
23 B/o CHITHRA 50.6 51.2 52 52.7 
24 B/o SUMITHRA 48.6 49.5 50 51.2 
25 B/o SANKARI 48.6 49.5 50 51.0 
26 B/o SANDHYA 48.0 48.8 50 50.4 
27 B/o NEELA VENI 50.3 51.0 52 52.1 
28 B/o JAYAMALINI 48.0 48.7 50 50.2 
29 B/o RADHIKA 50.2 51.0 52 52.4 
30 B/o ARCHANA 49.2 50.0 51 51.7 
31 B/o MANGAI 50.0 50.7 51 52.2 
32 B/o DEVI 48.3 49.1 50 51.0 
33 B/o JEYA 50.5 51.2 52 52.7 
34 B/o GOWTHAMI 50.6 51.4 52 52.9 
35 B/o SEETHA 49.0 49.8 51 51.3 
36 B/o SENTHAMARAI 49.0 49.8 51 51.4 
37 B/o RUBINI 50.4 51.2 52 52.8 
38 B/o GEETHA 51.8 52.6 53 54.1 
39 B/o TAMILARASI 50.6 51.3 52 53.0 
40 B/o RAMYA 48.6 49.5 50 51.4 
41 B/o SATHYA 48.7 49.8 51 51.7 
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42 B/o SOUNDARYA 49.6 50.6 52 52.5 
43 B/o KAMALA 50.6 51.5 53 53.4 
44 B/o SELVI 48.5 49.4 50 51.4 
45 B/o DEVI 50.8 51.7 53 53.6 
46 B/o AMUDHA 49.5 50.4 51 52.3 
47 B/o VALARMATHY 48.4 49.1 50 50.8 
48 B/o VENNILA 50.6 51.4 52 52.7 
49 B/o JEYANTHI 49.1 50.0 51 51.5 
50 B/o SUMATHY 51.6 52.2 53 53.6 
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TERM - APPROPRIATE FOR GESTATIONAL BABIES - LENGTH   
SL. 
No 
NAME LEN_7 LEN_14 LEN_21 LEN_28 
51 B/o STELLA 51.8 52.6 53 53.7 
52 B/o VIJAYALAKSHMI 50.9 51.7 52 53.1 
53 B/o NALINI 49.4 50.0 51 51.5 
54 B/o SARASWATHY 53.0 53.5 54 54.9 
55 B/o BHUVANESHWARI 48.7 49.6 51 51.2 
56 B/o PRIYA 47.8 48.8 50 50.6 
57 B/o DHANALAKSHMI 50.6 51.4 53 53.1 
58 B/o PRAMILA 52.7 53.0 54 54.7 
59 B/o RAMANI 48.5 49.3 50 51.2 
60 B/o PREMA 47.0 47.8 49 49.2 
61 B/o KANCHANA 52.2 53.0 54 54.2 
62 B/o SANGEETHA 47.6 38.4 49 50.0 
63 B/o VISALATCHI 48.4 49.0 50 50.6 
64 B/o VIJAYALAKSHMI 49.6 50.5 52 52.4 
65 B/o AGASTHIA 49.6 50.4 52 52.4 
66 B/o SURYA 47.6 48.4 50 50.9 
67 B/o DEEPA 52.0 52.7 54 54.0 
68 B/o SARANYA 47.3 48.0 49 49.7 
69 B/o DEVI 48.0 48.8 50 50.6 
70 B/o ELLAMMMA 51.0 51.6 52 53.0 
71 B/o RAASATHI 48.0 48.7 50 50.6 
72 B/o VAIDEGI 49.6 50.4 51 52.1 
73 B/o SAVITHRI 48.9 49.8 51 51.7 
74 B/o FARHANA 48.0 48.9 50 50.7 
75 B/o AMMANI 52.0 52.8 54 54.0 
76 B/o KAVITHA 48.7 49.6 51 51.5 
77 B/o PREETHA 51.9 52.6 54 54.0 
78 B/o SUMATHY 47.7 48.4 49 49.7 
79 B/o DEEPA 48.0 48.7 50 50.0 
80 B/o KAVITHA 53.0 53.7 54 54.5 
81 B/o DEVI 49.0 49.6 51 51.5 
82 B/o SARANYA 50.7 51.5 53 53.4 
83 B/o SANGEETHA 51.5 52.4 53 54.0 
84 B/o RAMYA 52.0 52.6 53 53.6 
85 B/o REVATHY 49.5 50.4 51 51.6 
86 B/o SEETHA 49.6 50.5 52 52.4 
87 B/o NADHIYA 50.5 51.5 52 53.4 
88 B/o USHA 48.6 49.2 50 50.6 
89 B/o SUMATHY 47.8 48.5 49 50.0 
90 B/o LATHA 47.9 48.7 50 50.6 
91 B/o LAKSHMI 49.5 50.4 51 52.2 
92 B/o SHALINI 51.9 52.7 53 53.6 
93 B/o KAMALA 53.0 53.6 55 55.1 
94 B/o REVATHY 49.2 50.0 50 51.0 
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95 B/o SARITHA 47.9 48.7 50 50.6 
96 B/o GEETHA 49.0 49.9 51 51.8 
97 B/o PRIYA 52.0 52.6 53 54.2 
98 B/o SARANYA 51.0 51.6 52 53.0 
99 B/o NADHIYA 52.0 52.7 53 53.8 
100 B/o LATHA 48.0 48.9 50 50.7 
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TERM - SMALL FOR GESTATIONAL AGE BABIES - HEAD CIRCUMFERENCE    
SL. 
No 
NAME HC_7 HC_14 HC_21 HC_28 
1 B/o MAHALAKSHMI 36.1 36.6 37 37.5 
2 B/o GEETHA SALIM 36.5 37.0 38 38.1 
3 B/o MADHAVI 37.1 37.5 38 38.6 
4 B/o SUMATHY 35.1 35.7 36 36.6 
5 B/o SARALA 35.9 36.4 37 37.2 
6 B/o USHA 37.4 37.8 38 38.5 
7 B/o MAHALAKSHMI 36.5 37.0 37 38.0 
8 B/o LATHA 36.7 37.1 38 38.2 
9 B/o JEYALAKSHMI 35.7 36.1 37 37.1 
10 B/o THAVAMANI 36.1 36.6 37 37.5 
11 B/o GEETHA KUMAR 36.7 37.1 38 38.0 
12 B/o SANTHANA MARI 36.9 37.2 38 38.1 
13 B/o VIJI 35.7 36.2 37 37.1 
14 B/o GANDHIMATHY 36.5 36.9 37 37.9 
15 B/o REVATHY 36.9 37.4 38 38.2 
16 B/o GANGA DEVI 36.1 36.5 37 37.5 
17 B/o SEETHA 34.7 35.2 36 36.2 
18 B/o NADHIYA 34.5 34.9 35 36.0 
19 B/o DEIVARATCHAGI 36.1 36.5 37 37.5 
20 B/o AARTHY 35.0 35.4 36 36.4 
21 B/o VEERASELVI 37.2 37.7 38 38.5 
22 B/o KAROLINE 35.1 35.5 36 36.5 
23 B/o CHITHRA 36.2 36.7 37 37.7 
24 B/o SUMITHRA 36.1 36.6 37 37.4 
25 B/o SANKARI 34.9 35.4 36 36.4 
26 B/o SANDHYA 34.9 35.4 36 36.4 
27 B/o NEELA VENI 35.9 36.4 37 37.4 
28 B/o JAYAMALINI 35.6 36.0 37 37.1 
29 B/o RADHIKA 36.2 36.7 37 37.5 
30 B/o ARCHANA 35.0 35.9 36 36.9 
31 B/o MANGAI 36.4 36.9 37 37.9 
32 B/o DEVI 34.7 35.1 36 36.1 
33 B/o JEYA 35.6 36.0 37 37.0 
34 B/o GOWTHAMI 36.4 36.9 37 37.9 
35 B/o SEETHA 35.6 36.0 36 37.0 
36 B/o SENTHAMARAI 34.7 35.1 36 36.1 
37 B/o RUBINI 36.1 36.6 37 37.5 
38 B/o GEETHA 34.6 35.1 36 36.1 
39 B/o TAMILARASI 35.0 35.4 36 36.4 
40 B/o RAMYA 35.9 36.4 37 37.4 
41 B/o SATHYA 35.6 36.1 37 37.1 
42 B/o SOUNDARYA 36.0 36.4 37 37.4 
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43 B/o KAMALA 36.9 37.4 38 38.3 
44 B/o SELVI 36.4 36.9 37 37.8 
45 B/o DEVI 36.1 36.6 37 37.5 
46 B/o AMUDHA 35.8 36.0 36 36.9 
47 B/o VALARMATHY 34.5 34.9 35 35.9 
48 B/o VENNILA 36.0 36.4 37 37.3 
49 B/o JEYANTHI 35.2 35.7 36 36.6 
50 B/o SUMATHY 36.0 36.4 37 37.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
117 
 
TERM - APPROPRIATE FOR GESTATIONAL BABIES - HEAD CIRCUMFERENCE    
SL. 
No 
NAME HC_7 HC_14 HC_21 HC_28 
1 B/o STELLA 37.1 37.6 38 38.5 
2 B/o VIJAYALAKSHMI 36.9 37.4 38 38.3 
3 B/o NALINI 36.1 36.6 37 37.5 
4 B/o SARASWATHY 36.0 36.5 37 37.4 
5 B/o BHUVANESHWARI 37.0 37.4 38 38.3 
6 B/o PRIYA 37.0 37.5 38 38.4 
7 B/o DHANALAKSHMI 36.2 36.7 37 37.7 
8 B/o PRAMILA 37.2 37.6 38 38.4 
9 B/o RAMANI 37.2 37.6 38 38.4 
10 B/o PREMA 36.7 37.1 38 38.0 
11 B/o KANCHANA 37.2 37.6 38 38.4 
12 B/o SANGEETHA 36.3 36.8 37 37.8 
13 B/o VISALATCHI 36.1 36.6 37 37.5 
14 B/o VIJAYALAKSHMI 35.0 35.5 36 36.5 
15 B/o AGASTHIA 37.0 37.4 38 38.3 
16 B/o SURYA 36.8 37.2 38 38.2 
17 B/o DEEPA 36.6 37.1 38 38.0 
18 B/o SARANYA 36.0 36.5 37 37.5 
19 B/o DEVI 37.0 37.4 38 38.3 
20 B/o ELLAMMMA 35.8 36.3 37 37.4 
21 B/o RAASATHI 37.0 37.5 38 38.4 
22 B/o VAIDEGI 36.7 37.2 38 38.2 
23 B/o SAVITHRI 37.0 37.5 38 38.4 
24 B/o FARHANA 37.0 37.5 38 38.4 
25 B/o AMMANI 37.0 37.5 38 38.4 
26 B/o KAVITHA 37.0 37.5 38 38.4 
27 B/o PREETHA 36.3 36.9 37 37.9 
28 B/o SUMATHY 37.0 37.5 38 38.4 
29 B/o DEEPA 37.0 37.5 38 38.4 
30 B/o KAVITHA 35.9 36.4 37 37.4 
31 B/o DEVI 36.4 36.9 37 37.9 
32 B/o SARANYA 36.0 36.5 37 37.5 
33 B/o SANGEETHA 37.2 37.7 38 38.7 
34 B/o RAMYA 36.0 36.5 37 37.5 
35 B/o REVATHY 36.1 36.6 37 37.7 
36 B/o SEETHA 37.0 37.5 38 38.4 
37 B/o NADHIYA 35.7 36.2 37 37.0 
38 B/o USHA 35.5 36.0 37 37.0 
39 B/o SUMATHY 35.4 35.9 36 36.8 
40 B/o LATHA 36.1 36.6 37 37.5 
41 B/o LAKSHMI 36.7 37.1 38 38.1 
42 B/o SHALINI 37.1 37.5 38 38.4 
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43 B/o KAMALA 36.8 37.2 38 38.2 
44 B/o REVATHY 36.2 36.7 37 37.7 
45 B/o SARITHA 36.8 37.2 38 38.2 
46 B/o GEETHA 36.2 36.7 37 37.7 
47 B/o PRIYA 37.0 37.5 38 38.4 
48 B/o SARANYA 36.1 36.6 37 37.6 
49 B/o NADHIYA 37.0 37.5 38 38.4 
50 B/o LATHA 37.0 37.5 38 38.4 
 
 
